




































































Many	 studies	 in	murine	models	 have	 demonstrated	 the	 stem/progenitor	 cell	 potential	 of	




Here,	methods	 to	 expand	 primary	 human	 airway	 epithelial	 cells	 from	 living	 patients	were	
explored.	 The	 field’s	 ‘gold	 standard’	 medium	 for	 the	 expansion	 of	 these	 cells	 was	 poorly	
suited	 to	 initiating	 cultures	 from	 small	 endobronchial	 biopsy	 samples	 as	 proliferation	 of	
these	 cells	 was	 time-limited	 and	 after	 a	 short	 period	 of	 time	 in	 culture	 the	 cells	 became	
senescent	and	were	unable	 to	 regenerate	a	mucociliary	epithelium	 in	organotypic	models.	
As	such,	an	alternative	epithelial	culture	strategy	 involving	the	co-culture	of	human	airway	
epithelial	 cells	 with	 3T3-J2	 fibroblast	 feeder	 cells	 in	 medium	 containing	 a	 small	 molecule	
Rho-associated	protein	kinase	(ROCK)	inhibitor	was	assessed.	This	method	greatly	improved	
both	the	yield	and	the	longevity	of	human	basal	cell	cultures	and	allowed	multipotent	airway	
differentiation	 in	 organotypic	 assays	 after	 longer	 culture	 periods	 than	 conventional	
techniques.	Finally,	 the	epithelial-stromal	 cell	 crosstalk	between	epithelial	 cells	and	 feeder	













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Antibody	 Species	 Isotype	 Supplier	 Product	Code	 Dilution	Factor	
Pan-cytokeratin	
(Epithelial	cells)	
Rabbit	 IgG	 Abcam	 ab9377	 1/400	
E-cadherin	
(Epithelial	cells)	
Mouse	 IgG1	 Abcam	 ab1416	 1/200	
CD31	
(Endothelial	cells)	
Mouse	 IgG1	 Abcam	 ab9498	 1/200	
CD45	
(Haematopoetic	cells)	
Rabbit	 IgG	 Abcam	 ab10558	 1/200	
Cytokeratin	5	
(Airway	basal	cells)	
Rabbit	 IgG	 Abcam	 ab24647	 1/400	
Cytokeratin	8	
(Airway	luminal	cells)	
Mouse	 IgG1	 Abcam	 ab9023	 1/400	
Cytokeratin	14	
(Airway	basal	cells)	
Mouse	 IgG3	 Novus	 NB600-1190	 1/400	
Cytokeratin	14	
(Airway	basal	cells)	












Rabbit	 IgG	 Abcam	 ab40273	 1/200	
ACT	
(Airway	ciliated	cells)	
Mouse	 IgG2b	 Sigma	 T6793	 1/500	
FOXJ1	
(Airway	ciliated	cells)	
Mouse	 IgG1	 Abcam	 ab40869	 1/200	
p63	
(Airway	basal	cells)	
Rabbit	 IgG	 Abcam	 ab53039	 1/200	
NGFR	
(Airway	basal	cells)	
Goat	 IgG	 Abcam	 ab87472	 1/200	
TROP2	
(Airway	basal	cells)	
Rabbit	 IgG	 Abcam	 ab65005	 1/200	
ITGA6	
(Airway	basal	cells)	
Mouse	 IgG2b	 Abcam	 ab20142	 1/200	
Ki67	
(Proliferating	Cells)	












































































































































































































































Antibody	 Species	 Isotype	 Supplier	 Product	Code	 Dilution	Factor	
Y397	FAK	 Rabbit	 IgG	 Cell	Signaling	 8556	 1/1000	
Y576/Y577	FAK	 Rabbit	 IgG	 Cell	Signaling	 3281	 1/1000	
Y925	FAK	 Rabbit	 IgG	 Cell	Signaling	 3284	 1/1000	
Total	FAK	 Rabbit	 IgG	 Cell	Signaling	 13009	 1/1000	
Y307	GAB1	 Rabbit	 IgG	 Cell	Signaling	 3234	 1/1000	
Y1003	MET	 Rabbit	 IgG	 Cell	Signaling	 3135	 1/1000	
Y1234/Y1235	MET	 Rabbit	 IgG	 Cell	Signaling	 3077	 1/1000	
Y1349	MET	 Rabbit	 IgG	 Cell	Signaling	 3133	 1/1000	
Total	MET	 Rabbit	 IgG	 Cell	Signaling	 8198	 1/1000	WB	1/50	IP	
Y452	GAB2	 Rabbit	 IgG	 Cell	Signaling	 3881	 1/1000	
Total	GAB2	 Rabbit	 IgG	 Cell	Signaling	 3239	 1/1000	
Y641	STAT6	 Rabbit	 IgG	 Cell	Signaling	 9361	 1/1000	
Total	STAT6	 Rabbit	 IgG	 Cell	Signaling	 9362	 1/1000	
MEK1/2	 Rabbit	 IgG	 Cell	Signaling	 8727	 1/1000	
Histone	H3	 Rabbit	 IgG	 Cell	Signaling	 4499	 1/1000	



































































































































































































































































































































































































































































































































































































































































































































01p 126.8 1.021 
01q 305.2 1.054 
02p 134.2 1.117 
02q 313.4 0.973 
03p 141.8 1.137 
03q 321.8 0.985 
04p 150.5 1.044 
04q 330.1 0.931 
05p 158.8 0.952 
05q 338.3 0.932 
06p 166.0 1.114 
06q 345.1 0.976 
07p 173.0 0.957 
07q 354.3 1.045 
08p 179.9 1.069 
08q 360.6 0.994 
09p 186.6 0.984 
09q 370.1 0.980 
10p 194.3 1.040 
10q 378.0 1.000 
11p 201.8 1.067 
11q 384.9 0.966 
12p 209.6 1.011 
12q 393.1 1.043 
13p 219.2 0.966 
13q 401.2 0.900 
14p 228.6 1.000 
14q 409.6 0.963 
15p 236.4 0.995 
15q 424.1 1.047 
16p 243.7 1.152 
16q 424.1 0.947 
17p 252.6 0.991 
17q 433.2 1.057 
18p 259.0 0.996 
18q 441.1 1.014 
19p 266.6 0.905 
19q 448.3 1.268 
20p 275.3 0.998 
20q 457.2 1.057 
21p 282.9 0.962 
21q 464.0 1.205 
22p 288.4 1.000 
22q 472.5 1.234 
SHOX 296.9 0.933 
SYBL1 481.5 1.092 
X 100.9 1.020 
Y1 105.2 -1 
Y2 114.8 -1 
	
Table	4.1:	Table	of	individual	probe	ratios	from	multiplex	ligation-dependent	probe	amplification	(MLPA)	
comparison	of	matched	donor	cell	line	and	reference	patient	biopsy.	
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Differentiation	capacity	of	expanded	basal	cells	is	better	maintained	in	3T3+Y	than	in	BEGM	
	
Since	basal	cells	expanded	in	3T3+Y	retain	the	capacity	to	form	a	stable,	confluent	epithelial	
layer,	the	capacity	of	these	cells	for	in	vitro	airway	differentiation	was	investigated.	Firstly,	
cells	were	cultured	at	an	air-liquid	interface	to	establish	their	differentiation	capabilities	at	
either	early	(P1)	or	late	(P4)	passages.	For	comparison	with	earlier	results	using	BEGM,	
matched	cells	grown	in	BEGM	or	3T3+Y	were	compared.	During	expansion	in	either	culture	
system,	all	basal	cells	were	p63+	but,	after	≥4	weeks	in	air-liquid	interface,	only	a	subset	of	
cells	retained	p63	expression,	indicating	that	differentiation	occurred	in	all	conditions	
(Figure	4.6A).	Acetylated	α-tubulin	(ACT)	staining	of	these	cultures	revealed	extensive	
ciliation	in	cultures	derived	from	early	passage	(P1)	basal	cells	in	either	BEGM	or	3T3+Y	
(Figure	4.6B).	However,	at	late	passage	(P4)	only	the	3T3+Y-derived	cultures	persisted	for	
the	full	6	weeks	of	the	experiment	due	to	problems	with	epithelial	integrity	in	BEGM-derived	
cultures.	Importantly,	very	few	ciliated	cells	were	seen	in	late	passage	BEGM-derived	
cultures,	indicating	that	basal	cells	expanded	in	BEGM	lose	their	capacity	for	ciliated	
differentiation	by	passage	4	(Figure	4.6B).	Interestingly,	extensive	ciliation	comparable	to	P1	
cultures	was	seen	in	late	passage	3T3+Y-derived	cultures,	indicating	that	basal	cells	
expanded	in	3T3+Y	maintain	their	differentiation	capacity	over	passage.		
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Figure	4.6:	Air-liquid	interface	cultures	reveal	a	decline	in	basal	cell	differentiation	capacity	over	time	in	cells	
cultured	in	BEGM	but	not	in	3T3+Y.	A)	Top-down	immunofluorescence	staining	shows	that	a	subset	of	cells	
expanded	in	all	conditions	express	p63	after	6	weeks	of	air-liquid	interface	(ALI)	culture.	DAPI	is	used	as	a	
counterstain.	Scale	bars	=	50	μm.	B)	Staining	for	acetylated	α-tubulin	(ACT)	shows	ciliated	epithelial	cells	in	air-
liquid	interface	cultures	derived	from	early	passage	bronchial	epithelial	growth	medium	(BEGM)	and	both	early	
and	late	passage	3T3-J2	co-culture	with	ROCK	inhibition	(3T3+Y)	cultures.	DAPI	is	used	as	a	counterstain.	Scale	
bars	=	50	μm.	
	
	
	
Through	collaboration	with	Professor	Chris	O’Callaghan’s	laboratory	(Institute	of	Child	
Health,	University	College	London),	the	functional	capacity	of	the	ciliated	epithelium	
generated	using	air-liquid	interface	cultures	from	basal	cells	expanded	in	3T3+Y	was	
investigated.	After	6	weeks,	the	cultures	had	very	high	transepithelial	electrical	resistance	
(TEER)	values	(Figure	4.7A),	indicative	of	high	epithelial	integrity	[272].	Further,	high-speed	
video	microscopy	and	scanning	electron	microscopy	investigations	revealed	that	the	ciliary	
beat	and	frequency	were	within	the	normal	range	[273]	(Figure	4.7A)	and	that	ciliary	
ultrastructure	[274]	was	normal	(Figure	4.7B).	
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Figure	4.7:	Ciliary	function	and	ultrastructure	are	normal	in	3T3+Y-derived	air-liquid	interface	cultures.	A)	In	air-
liquid	interface	cultures,	the	transepithelial	electrical	resistance	(TEER),	ciliary	beat	frequency	and	ciliary	beat	
pattern	were	characterised	in	collaboration	with	Professor	Chris	O’Callaghan’s	laboratory	(Institute	of	Child	
Health,	University	College	London).	Results	are	shown	as	mean	±	SEM.	B)	Transmission	electron	microscopy	
(TEM)	shows	a	healthy	well-ciliated	strip	of	respiratory	epithelium	from	air-liquid	interface	cultures.	Normal	
columnar	cells	and	microvilli	are	seen	(scale	bar	=	10	µm).	The	electron	micrograph	on	the	right	shows	cilia	in	
cross	section.	A	normal	ciliary	ultrastructure	is	seen	with	the	typical	9	+	2	arrangement	of	microtubules	and	inner	
and	outer	dynein	arms	(scale	bar	=	1	µm).	
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In	addition	to	air-liquid	interface	assays,	differentiation	of	cells	grown	in	BEGM	was	
compared	with	matched	donor	cells	grown	in	3T3+Y	in	a	three-dimensional	(3D)	
tracheosphere	assay.	Here,	single	cultured	airway	basal	cells	are	grown	in	a	3D	Matrigel	
matrix	and	form	spheroids	over	the	culture	period.	These	undergo	lumen	formation	and	
contain	differentiated	airway	cell	types	at	the	luminal	surface	[15].	As	in	Figure	4.6,	early	
(P1)	and	late	(P4)	passage	cultures	were	compared	to	examine	whether	differentiation	
potential	is	maintained	over	passage.	The	size	of	tracheospheres	derived	from	3T3+Y	basal	
cells	was	not	affected	by	passage	whereas	tracheospheres	derived	from	passage	4	BEGM	
cells	were	smaller	than	those	derived	from	passage	1	BEGM	cells	(Figure	4.8A	and	Figure	
4.8B).	When	differentiation	status	of	tracheospheres	was	assessed,	p63	was	expressed	in	all	
of	the	cells	on	the	basal	surface	of	spheroids	(Figure	4.8C),	consistent	with	its	expression	in	
basal	epithelial	cells	that	contact	the	basement	membrane	in	vivo.	At	early	passage	(P1),	
both	BEGM	and	3T3+Y	cultures	gave	rise	to	tracheospheres	with	evidence	of	mucin	5B	
(MUC5B)+	goblet	cells	and	ACT+	ciliated	cells	(Figure	4.8D).	However,	at	late	passage	(P4),	
only	cells	cultured	in	3T3+Y	showed	this	multipotent	differentiation	capacity	(Figure	4.8D).	
At	late	passage,	the	tracheospheres	that	did	form	(see	Figure	4.8B)	displayed	abnormal	
lumen	formation	and	did	not	show	evidence	of	ciliated	differentiation	(Figure	4.8D).	
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Figure	4.8:	Airway	basal	cells	expanded	in	3T3+Y	form	well	differentiated	tracheospheres	at	later	passage	than	
those	expanded	in	BEGM.	A)	Quantification	of	tracheosphere	size	at	early	(P1)	and	late	(P4)	passage	in	bronchial	
epithelial	growth	medium	(BEGM)	and	3T3-J2	co-culture	with	ROCK	inhibition	(3T3+Y).	Mean	+/-	SEM	is	shown.	
B)	Brightfield	images	show	morphology	of	tracheospheres	derived	from	basal	cells	cultured	in	BEGM	or	3T3+Y	for	
one	passage	(top	row)	or	four	passages	(bottom	row).	Scale	bar	=	500	µm.	C)	Immunofluorescence	staining	
shows	tracheosphere	p63	expression.	Scale	bar	=	100	µm.	D)	Immunofluorescence	staining	of	tracheospheres	
generated	from	cells	grown	in	either	BEGM	(P1	and	P4)	or	3T3+Y	(P1	and	P4)	for	acetylated	α-tubulin	(ACT;	
green),	mucin	5B	(MUC5B;	red)	and	DAPI	(blue).	Scale	bars	=	50	µm.	
	
The	multipotent	differentiation	capacity	of	airway	basal	cells	grown	in	3T3+Y	was	further	
investigated	by	adaptation	of	a	second	submerged	airway	differentiation	protocol	[239].	
Here,	cell	suspensions	were	incubated	in	a	non-adherent	96-well	plate	on	a	plate	shaker	and	
single	aggregates	of	cells	were	formed	(Figure	4.9A).	This	technique	confers	the	benefit	of	
having	ciliated	epithelial	cells	on	the	surface	of	airway	spheroids,	as	opposed	to	in	3D	
tracheospheres	where	cilia	are	contained	within	the	3D	structure,	a	factor	that	might	limit	
their	relevance	in	drug	or	toxicology	exposure	studies.	After	three	weeks	of	culture,	
histology	revealed	a	continuous	epithelial	structure	containing	acini	(Figure	4.9B).	
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Immunofluorescence	staining	showed	that	aggregates	contained	MUC5B+	mucosecretory	
cells	and	were	lined	by	ACT+	ciliated	cells	(Figure	4.9C),	further	indicating	that	basal	cells	
expanded	in	3T3+Y	maintain	their	multipotent	differentiation	capacity.	
	
	
	
Figure	4.9:	Differentiation	of	airway	basal	cells	expanded	in	3T3+Y	using	an	aggregate	culture	method.	A)	
Brightfield	image	showing	cell	aggregate	in	a	96-well	plate	well.	Scale	bar	=	500	µm.	B)	Haemotoxylin	and	eosin	
staining	of	a	cell	aggregate	after	23	days	of	culture.	Scale	bar	=	50	µm.	C)	Immunofluorescence	staining	of	a	cell	
aggregate	showing	mucin	5B	(MUC5B)+	mucus	(green),	acetylated	α-tubulin	(ACT)+	ciliated	cells	(red)	and	cell	
nuclei	(DAPI;	blue).	Scale	bar	=	50	µm.	
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Microarray	analysis	
	
Given	the	remarkable	effects	of	3T3+Y	culture	on	basal	cell	expansion	in	vitro	and	the	
maintenance	of	differentiation	over	longer	periods	in	these	cultures,	genome-wide	
transcriptional	profiling	was	performed	using	microarrays	to	explore	the	major	pathways	
altered	by	3T3+Y	culture.	After	initial	expansion	in	BEGM,	four	matched	donor	cell	lines	
grown	in	either	BEGM	or	3T3+Y	for	7	days	were	compared.	Data	were	analysed	using	the	
significance	analysis	of	microarrays	method	with	a	false	discovery	rate	of	5%:	507	
significantly	differentially	expressed	transcripts	were	found,	297	of	which	were	
downregulated	in	3T3+Y	and	210	of	which	were	upregulated.	Significant	differences	were	
visualised	in	a	cluster	diagram	(Figure	4.10A)	that	clearly	shows	clustering	of	expression	
according	to	culture	condition	rather	than	donor.	Even	when	selected	airway-relevant	genes	
were	analysed,	independently	of	whether	differences	were	significant,	cells	remained	
clustered	according	to	culture	condition	rather	than	donor	(Figure	4.10B).	
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Figure	4.10:	Microarray	analysis	reveals	differentially	expressed	genes	in	matched	donor	cells	expanded	in	
3T3+Y	or	BEGM.	A)	Cluster	diagram	plotting	significantly	differentially	expressed	genes	between	cells	grown	for	
one	passage	in	either	bronchial	epithelial	growth	medium	(BEGM)	or	in	3T3-J2	co-culture	with	ROCK	inhibition	
(3T3+Y).	B)	Cluster	diagram	showing	selected	airway	epithelial	genes	of	interest,	including	markers	of	basal	cells,	
goblet	cells	and	ciliated	cells.	Selected	airway-relevant	genes	are	shown	regardless	of	whether	differences	are	
significant.	RNA	isolation	for	microarray	analysis	was	performed	by	Dr.	Colin	Butler.	
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To	highlight	pathways	in	which	the	genes	whose	expression	changed	significantly	between	
culture	conditions	might	be	involved,	we	used	Ingenuity	Pathway	Analysis	and	observed	
alterations	in	several	pathways,	including	cell	cycle	regulation	(Figure	4.11A),	which	
correlated	with	the	increased	proliferation	of	basal	cells	in	3T3+Y	shown	in	Figure	4.1.	
Functional	analysis	using	the	same	software	revealed	significant	upregulation	of	genes	
associated	with	cell	movement	and	proliferation	and	decreased	expression	of	genes	
associated	with	cell	death	in	3T3+Y	(Figure	4.11B).	
	
	
	
Figure	4.11:	Pathway	analysis	of	microarray	comparisons.	A)	Ingenuity	Pathway	Analysis	(IPA)	was	applied	to	
investigate	cell	signalling	pathways	containing	significantly	differentially	expressed	genes.	The	IPA	analysis	–log(p-
value)	is	plotted	on	the	y-axis	versus	biological	processes	on	the	x	axis.	B)	Functional	analysis	of	differentially	
expressed	genes	was	performed	using	IPA.	The	major	functions	altered	by	culture	in	3T3-J2	co-culture	with	ROCK	
inhibition	(3T3+Y)	are	shown,	along	with	the	relevant	–log(p-value)	and	the	top	10	relevant	genes	(5	upregulated	
and	5	downregulated).	Genes	already	displayed	in	a	function	were	subsequently	ignored	to	avoid	overlap.		
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In	order	to	validate	the	results	of	the	microarray,	the	expression	of	six	differentially	
expressed	genes	was	analysed	in	all	samples	by	qPCR;	these	results	showed	a	high	
correlation	with	the	microarray	(r	=	0.96;	Figure	4.12A).	Further,	the	expression	of	
secretoglobin	family	3A	member	1	(SCGB3A1),	the	most	significantly	different	gene,	was	
evaluated	by	western	blotting.	Antibody	validation	was	performed	by	staining	normal	
human	tracheal	epithelial	sections	and	confirming	its	expected	location	in	differentiated	
goblet	cells	(Figure	4.12B).	Consistent	with	its	upregulation	in	the	microarray	data,	SCGB3A1	
was	strongly	expressed	in	3T3+Y	but	not	in	matched	donor	cells	grown	in	BEGM	(Figure	
4.12C).	The	biological	significance	of	this	upregulation	is	unknown	as	the	protein	is	not	
expressed	in	human	basal	cells	in	vivo	(Figure	4.12B),	although	in	mice	SCGB3A1	expression	
may	be	increased	during	regeneration	[275].	
	
Overall,	these	results	indicate	that	3T3+Y	allows	the	prolonged	expansion	of	human	airway	
basal	epithelial	cells	with	multipotent	airway	differentiation	potential	in	vitro.	Our	
microarray	data	provide	a	resource	for	future	research	to	investigate	the	molecular	basis	of	
this	improvement	in	cell	culture	conditions.	
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Figure	4.12:	Validation	of	microarray	data	using	qPCR	and	western	blotting.	A)		Correlation	between	microarray	
fold	change	(3T3+Y/BEGM)	and	qPCR	fold	change	(3T3+Y/BEGM).	Pearson’s	r	is	shown.	B)	Immunofluorescence	
staining	of	normal	human	airway	epithelium	showing	pan-cytokeratin	(PANCK;	green),	secretoglobin	family	3A	
member	1	(SCGB3A1;	red)	and	cell	nuclei	(DAPI;	blue).	Scale	bar	=	20	µm.	C)	Western	blot	confirmation	of	
upregulated	SCGB3A1	expression	in	donor-matched	cells	grown	in	3T3-J2	co-culture	with	ROCK	inhibition	(3T3+Y)	
compared	with	bronchial	epithelial	growth	medium	(BEGM).	
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4.4 Summary		
• Human	airway	epithelial	cells	are	rapidly	expanded	by	co-culture	with	mitotically	
inactivated	3T3-J2	cells	in	the	presence	of	a	ROCK	inhibitor	(3T3+Y).		
• 3T3+Y-expanded	epithelial	cells	express	markers	of	airway	basal	cells	and	show	
evidence	of	increased	expression	of	genes	associated	with	airway	basal	stem	cells.		
• Expanded	basal	cells	are	karyotypically	normal	and	contact	inhibited.		
• After	four	passages,	basal	cells	grown	in	BEGM	proliferate	more	slowly	and	have	
demonstrably	lost	the	capacity	for	multipotent	airway	epithelial	differentiation.	
However,	cells	grown	in	3T3+Y	are	still	capable	of	forming	epithelia	containing	both	
goblet	and	ciliated	cells.		
• Pathway	analysis	of	microarray	data	comparing	cells	expanded	in	BEGM	and	3T3+Y	
highlighted	pathways	that	may	be	relevant	to	future	investigations	to	unravel	the	
mechanisms	underpinning	the	success	of	3T3+Y	culture	
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5 .	Improvements	to	the	human	
airway	basal	epithelial	cell	co-
culture	system	to	improve	
suitability	for	tissue	engineering		
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5.1 Background	
	
Having	established	a	protocol	to	expand	human	airway	basal	stem/progenitor	cells	in	co-
culture	with	3T3-J2	fibroblasts	and	Rho-associated	protein	kinase	(ROCK)	inhibition	(3T3+Y)	
and	demonstrated	the	advantages	of	this	system	for	extending	the	usefulness	of	these	cells	
in	differentiated	primary	airway	cultures,	improvements	to	the	system	were	investigated.	
Firstly,	if	tissue-engineered	airway	transplantation	is	to	enter	clinical	trials	and	eventually	to	
produce	novel	therapeutic	options,	then	GMP-compliance	will	be	necessary.	For	this,	co-
culture	of	human	epithelial	cells	with	3T3-J2	fibroblasts	is	not	ideal	due	to	the	murine	origin	
of	the	cells,	although	such	methods	have	been	approved	in	other	epithelial	organs	[190,	
194-196,	276].	The	co-culture	of	airway	epithelial	cells	with	alternative	stromal	cells	was	
investigated	to	establish	whether	stromal	cells	derived	from	patients	could	be	used	to	create	
autologous,	human	feeder	layers.	Secondly,	previous	data	were	gathered	using	epithelial	
cells	that	were	isolated	in	bronchial	epithelial	growth	medium	(BEGM)	for	one	passage	prior	
to	investigation,	so	assessments	of	whether	using	3T3+Y	for	the	isolation	of	airway	epithelial	
cells	were	made	with	the	expectation	that	this	would	increase	the	culture	success	rate	and	
reduce	the	amount	of	time	required	to	establish	cultures.	In	addition,	we	examined	whether	
outgrowth	from	biopsy	samples	was	the	optimal	way	to	isolate	airway	epithelial	cells:	we	
compared	outgrowth	from	biopsy	samples	and	from	single	cell	suspensions	generated	by	
digestion	of	biopsy	samples	and	endobronchial	brushings.	Finally,	the	potential	use	of	3T3-
J2-conditioned	medium	instead	of	co-culture	with	feeder	cells	was	investigated,	as	this	
would	eliminate	the	need	for	direct	contact	with	mouse	cells	and	would	therefore	be	more	
suitable	to	grow	epithelial	cells	for	tissue-engineering	applications.			
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5.2 Aims	
	
• To	investigate	whether	human-derived	stromal	cells	can	replace	3T3-J2	cells	in	co-
culture	protocols.	
• To	investigate	and	to	optimise	the	outgrowth	of	airway	epithelial	cells	from	
endobronchial	biopsy	samples	directly	in	3T3+Y.	
• To	investigate	whether	3T3-J2-conditioned	medium	can	replace	co-culture	with	3T3-
J2	feeder	cells.																						
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5.3 Results	
Replacement	of	3T3-J2	feeder	cells	with	alternative	stromal	feeder	cells		
	
The	ability	to	derive	feeder	cells	on	a	patient-specific	basis	rather	than	to	rely	on	a	murine	
embryonic	cell	line	is	appealing	for	translational	purposes,	so	plausible	human	feeder	cell	
candidates	were	investigated	as	a	3T3-J2	replacement.	Human	lung	fibroblasts	were	
assessed	given	the	ease	of	fibroblast	isolation	from	small	patient	tissue	samples	[277]	as	well	
as	human	bone	marrow-derived	mesenchymal	stromal	cells	(MSCs)	because	these	have	
been	used	in	an	autologous	fashion	in	previous	tissue-engineered	airway	grafts	[70,	71].	
Feeder	layers	were	prepared	in	the	same	way	as	for	3T3-J2	cells:	that	is,	stromal	cells	were	
mitotically	inactivated	by	2-hour	treatment	with	mitomycin	C	prior	to	epithelial	cell	seeding	
the	following	day,	and	epithelial	growth	medium	containing	5	μM	Y-27632	was	used	for	co-
cultures.	Promisingly,	colonies	of	epithelial	cells	with	a	similar	morphology	to	those	seen	in	
co-culture	with	3T3-J2	feeder	layers	emerged	during	the	first	passage	in	co-cultures	with	
both	MSCs	and	lung	fibroblasts	(Figure	5.1A),	although	epithelial	cells	appeared	to	
proliferate	more	slowly	on	both	of	the	human	feeder	layers.	Unfortunately,	after	
trypsinisation,	substantial	differences	in	both	cell	morphology	and	cell	number	appeared	
between	the	epithelial	cells	grown	in	co-culture	with	3T3-J2	feeder	layers	and	those	grown	
in	co-culture	with	either	of	the	human	alternatives	(Figure	5.1A).	Flow	cytometry	after	
passage	one	confirmed	that	integrin	α6+/nerve	growth	factor	receptor	(NGFR)+/TROP2+	
airway	basal	cells	were	expanded	in	all	conditions	(Figure	5.1C).	Co-culture	with	alternative	
feeder	cells	induced	higher	levels	of	expression	of	these	basal	stem	cell	markers	compared	
with	BEGM,	although	not	to	the	same	level	as	co-culture	in	3T3+Y	in	the	case	of	NGFR	and	
TROP2	expression.	Although	one	further	passage	of	these	cells	was	possible	(Figure	5.1B),	
these	cells	were	not	tested	in	terms	of	their	differentiation	capacity	because	the	alternative	
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feeder	layers	did	not	improve	cell	expansion	compared	with	BEGM	(Figure	5.1B).	
Additionally,	it	was	noted	that	neither	human	lung	fibroblasts	nor	MSCs	share	the	high	
trypsin	sensitivity	of	3T3-J2	cells	so	reliable	separation	of	feeder	cells	and	epithelial	cells	is	
another	issue	that	would	need	to	be	addressed	in	attempts	to	replace	3T3-J2	feeder	cells.	
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Figure	5.1:	Mitotically	inactivated	allogeneic	human	bone	marrow-derived	MSCs	or	human	lung	fibroblast	
feeder	layers	cannot	replace	3T3-J2	fibroblasts	in	human	airway	basal	cell	culture	protocols.	A)	Representative	
brightfield	images	are	shown	for	airway	epithelial	cells	expanded	in	bronchial	epithelial	growth	media	(BEGM)	or	
in	co-culture	with	3T3+Y,	mitotically	inactivated	human	lung	fibroblasts	+	Y	or	mitotically	inactivated	human	bone	
marrow-derived	mesenchymal	stromal	cells	(MSCs)	+	Y.	Images	were	taken	after	one	passage	in	these	conditions	
(left)	and	after	two	passages	(right).	Scale	bar	=	50	µm.	B)	Cumulative	cell	population	doublings	for	airway	
epithelial	cells	grown	in	these	culture	conditions	are	plotted	over	time	(mean	+/-	SEM).	C)	Flow	cytometry	
confirmed	the	similarity	of	expression	of	the	basal	cell	proteins	integrin	α6,	nerve	growth	factor	receptor	(NGFR)	
and	TROP2	in	cells	cultured	in	these	conditions.	Epithelial	cells	were	gated	by	selection	of	DAPI-,	ITGA6+,	CD90-	
cells	(n	=	3,	representative	plots	shown).	
	
	
	
121	
 
Direct	plating	of	biopsy	samples	in	3T3+Y	
	
In	the	absence	of	an	appropriate	alternative	to	3T3-J2	feeder	cells,	methods	were	sought	to	
enhance	the	existing	protocol.	In	all	previous	experiments,	initial	cell	isolation	occurred	in	
BEGM	and	cells	were	subsequently	divided	into	matched	BEGM	and	3T3+Y	co-cultures	for	
comparison	of	these	methods.	Given	the	advantages	of	3T3+Y	compared	with	BEGM	in	
terms	of	proliferation	and	retention	of	basal	progenitor	cell	properties,	cell	isolation	directly	
in	3T3+Y	was	investigated.	Results	confirmed	that,	similarly	to	in	BEGM,	epithelial	cells	can	
be	expanded	from	endobronchial	biopsies	plated	in	3T3+Y	as	explants	(Figure	5.2A).	Also	
similarly	to	in	BEGM,	the	cells	that	expand	from	biopsies	are	CK5+/p63+	basal	epithelial	cells	
(Figure	5.2B-5.2D).	
	
	
	
	
	
	
Figure	5.2:	Direct	expansion	of	human	airway	basal	cells	from	endobronchial	biopsy	samples	in	3T3+Y.	A)	
Brightfield	image	showing	epithelial	cell	outgrowth	from	endobronchial	biopsy	explant	cultured	in	3T3-J2	co-
culture	with	ROCK	inhibition	(3T3+Y).	Scale	bar	=	100	µm.	B)	Immunofluorescence	staining	for	the	basal	cell	
marker	cytokeratin	5	(CK5).	Scale	bar	=	50	µm.	C)	Immunofluorescence	staining	for	the	basal	cell	marker	p63.	
Scale	bar	=	50	µm.	D)	Immunofluorescence	staining	for	the	proliferation	marker	Ki67.	Scale	bar	=	50	µm.	DAPI	is	
used	as	a	counterstain.	
	
122	
 
Although	airway	basal	cells	could	be	expanded	from	explant	biopsies	directly	in	3T3+Y,	the	
culture	time	for	satisfactory	epithelial	cell	outgrowth	from	biopsies	remained	at	10-14	days,	
which	is	similar	to	the	time	taken	for	cell	outgrowth	from	a	biopsy	in	BEGM.	Reducing	this	
lag	time	is	significant	for	translational	applications	as	some	tissue-engineering	indications	
are	urgent	[71,	81].	In	single,	large	explant	biopsy	cultures,	epithelial	cells	effectively	migrate	
from	the	biopsy	as	a	continuous	sheet	across	the	culture	plastic	(Figure	5.3A).	Seeding	single	
cells	was	therefore	investigated	as	an	alternative	with	the	aim	that	multiple	epithelial	cell	
colonies	would	form	and	proliferate,	yielding	a	greater	number	of	cells	more	quickly.	This	
was	achieved	either	through	the	enzymatic	digestion	of	endobronchial	biopsy	samples	to	
achieve	a	cell	suspension	that	could	then	be	plated	in	co-culture	or	through	using	a	cell	
suspension	derived	directly	from	an	endobronchial	brushing	sample.	As	expected,	these	new	
methods	allow	single	basal	cells	to	form	independent	colonies	from	the	very	beginning	of	
culture	and	mean	that	the	rapid	expansion	of	cells	begins	earlier	than	from	an	explant	
biopsy.	Indeed,	cultures	derived	from	either	a	biopsy	following	digestion	or	from	a	brushing	
yield	significantly	higher	numbers	of	cells	in	3T3+Y	than	those	derived	from	an	explant	
biopsy	(Figure	5.3C).	In	all	conditions,	the	expansion	of	integrin	α6+/CK5+	airway	basal	
epithelial	cells	was	demonstrated	using	flow	cytometry	(Figure	5.3D).	
	
Next,	the	success	rate	of	cultures	in	these	conditions	was	compared	as,	from	experience	of	
expanding	cells	in	BEGM,	we	knew	that	not	all	biopsies	that	are	plated	in	culture	yield	
successful	epithelial	cell	cultures.	In	our	laboratory,	the	success	rate	of	epithelial	cell	
expansion	from	explant	biopsies	is	around	50%	in	BEGM.	Here,	I	show	that	3T3+Y	culture	
enables	a	greater	culture	success	rate	for	biopsy	explant	than	BEGM,	with	successful	
epithelial	cultures	established	from	88%	of	biopsies	grown	in	these	conditions.	The	success	
rate	for	establishing	cultures	was	particularly	high	in	3T3+Y	when	single	cells	were	seeded	
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rather	than	explant	biopsies,	with	88%	and	94%	of	digested	biopsies	and	brushings,	
respectively,	giving	rise	to	epithelial	cultures	(Figure	5.3B).		
	
Investigation	of	3T3-J2-conditioned	medium	as	a	co-culture	alternative	
	
In	these	experiments	the	effect	of	using	3T3-J2-conditioned	medium	(CM+Y)	in	place	of	3T3-
J2	co-culture	was	investigated	as	this	could	be	preferable	in	a	translational	setting:	epithelial	
cells	could	be	expanded	without	contamination	with	murine	feeder	cells	even	in	the	absence	
of	a	detailed	understanding	of	the	active	components.	To	generate	conditioned	medium,	
3T3-J2	feeder	layers	were	prepared	using	mitomycin	C,	seeded	at	feeder	density	overnight	
and	epithelial	culture	medium	(without	Y-27632)	was	added	the	following	day.	Medium	was	
collected	and	replaced	after	24	hours	and	collected	again	after	48	hours,	based	on	a	
published	protocol	[278].	5	μM	Y-27632	was	added	to	the	conditioned	medium	and	it	was	
filtered	and	frozen	at	-80°C	for	future	use.	Basal	airway	epithelial	cells	expressing	integrin	α6	
and	CK5	could	be	isolated	in	3T3-J2-conditioned	medium	containing	5	μM	Y-27632	(Figure	
5.3A	and	5.3D)	with	the	same	(in	the	case	of	endobronchial	brushings)	or	slightly	lower	(in	
the	case	of	biopsy	or	digested	biopsy	samples)	culture	success	rates	than	direct	3T3+Y	co-
culture	(Figure	5.3B).	Similar	numbers	of	epithelial	cells	grew	from	biopsy	explants	or	
brushings	in	CM+Y	compared	with	3T3+Y.	Interestingly,	significantly	fewer	cells	grow	from	
digested	biopsies	when	they	were	plated	in	CM+Y	than	when	in	3T3+Y,	suggesting	that	the	
full	effect	of	co-culture	is	not	replicated	by	the	conditioned	medium	approach	(Figure	5.3C).	
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Figure	5.3:	Comparison	of	epithelial	cell	outgrowth	from	endobronchial	biopsy	samples	and	brushings	in	3T3+Y	
and	using	3T3-J2	feeder	cell-conditioned	medium.	A)	Brightfield	images	show	successful	epithelial	cell	
outgrowth	from	explant	endobronchial	biopsy,	enzymatically	digested	biopsy	and	endobronchial	brushing	
samples.	Scale	bar	=	50	µm.	B)	Comparison	of	culture	success	rate	in	either	3T3+Y	co-culture	with	ROCK	inhibition	
(3T3+Y)	or	using	3T3-J2-conditioned	medium	(CM+Y).	C)	Comparison	of	epithelial	cell	numbers	generated	after	
12	days	of	culture	in	either	3T3+Y	direct	co-culture	or	3T3-J2-conditioned	medium.	Statistical	analysis	was	
performed	using	a	two-way	ANOVA	with	Bonferroni	post-test;	mean	+/-	SEM;	*	indicated	p	<	0.05,	****	
p<0.0001;	n	=	8-14.	D)	Flow	cytometric	analysis	shows	that	integrin	α6-	and	CK5-expressing	basal	epithelial	cells	
are	expanded	in	all	of	these	conditions.	
	
Having	isolated	airway	basal	cells	from	biopsies,	digested	biopsies	and	brushings	in	3T3+Y	or	
in	3T3-J2-conditioned	medium,	these	cells	were	passaged	to	confirm	that	further	expansion	
was	possible	in	line	with	previous	findings	using	BEGM-isolated	basal	cells.	Cells	in	all	
conditions	could	be	expanded	at	passage	one	and	colonies	appeared	morphologically	
similar,	although	some	epithelial	cells	began	to	appear	larger	and	flatter	in	3T3-J2-
conditioned	medium,	suggesting	that	the	culture	may	not	be	as	‘healthy’	as	that	in	3T3+Y	co-
culture	(Figure	5.4A).	Passage	one	cells	maintained	their	expression	of	the	basal	cell	markers	
integrin	α6	and	CK5	(Figure	5.4B)	and	cells	isolated	and	cultured	in	3T3+Y	co-culture	
maintained	a	proliferative	advantage	over	those	isolated	and	cultured	in	3T3-J2-conditioned	
medium	(Figure	5.4C).	
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Figure	5.4:	Comparison	of	epithelial	cell	expansion	after	passage	in	3T3+Y	and	using	3T3-J2	feeder	cell-
conditioned	medium.	A)	Brightfield	images	show	the	similar	morphology	of	epithelial	cells	grown	in	3T3-J2	co-
culture	(3T3+Y)	and	in	3T3-J2-conditioned	medium	(CM+Y)	after	one	passage.	Scale	bar	=	50	µm.	B)	Flow	
cytometric	analysis	confirms	the	maintenance	of	integrin	α6	and	cytokeratin	5	(CK5)	expression	in	all	conditions	
after	one	passage.	C)	Summary	data	show	the	increased	number	of	cells	generated	from	direct	3T3-J2	co-culture	
compared	with	culture	in	3T3-J2-conditioned	medium.	Statistical	analysis	was	performed	using	a	two-way	
ANOVA	with	Bonferroni	post-test;	mean	+/-	SEM;	*	indicates	p	<	0.05;	**	p	=	0.01,	****	p<0.0001;	n	=	6-13.	
	
	
These	conditioned	medium	experiments	suggested	that	cell-cell	contact	between	3T3-J2	
feeder	cells	and	airway	epithelial	cells	is	necessary	for	the	maximal	proliferative	effect	of	co-
culture.	This	was	in	contrast	to	experiments	performed	in	epidermal	keratinocytes	that	
suggest	that	secreted	factors	mediate	the	full	effect	of	3T3-J2	feeder	cells	and	that	cell-cell	
contact	is	not	necessary	[278].	To	clarify	this,	the	colony-forming	efficiency	of	matched	
epithelial	cells	was	compared	when	3T3-J2s	were	in	direct	co-culture,	3T3-J2	cells	were	
physically	separated	from	epithelial	cells	by	a	transwell	membrane	or	3T3-J2-conditioned	
medium	was	used	[279].	Results	demonstrated	that,	while	conditioned	medium	did	allow	
the	formation	of	epithelial	colonies,	it	was	less	efficient	than	either	condition	in	which	3T3-
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J2	feeder	cells	were	present	(Figure	5.5).	The	similarity	in	the	number	of	colonies	formed	in	
the	conditions	in	which	epithelial	cells	were	in	direct	contact	with	the	epithelial	cells	and	in	
which	they	were	separated	by	a	transwell	membrane	supports	the	conclusion	that	diffusible	
factors	co-operate	with	ROCK	inhibition	to	improve	epithelial	cell	expansion	[278].	However,	
the	difference	between	the	number	of	epithelial	cell	colonies	generated	in	3T3-J2-
conditioned	medium	and	in	cultures	in	which	transwell	separation	was	used	implies	that	
epithelial	cells	require	a	continuous	supply	of	feeder	cell	factor(s),	which	was	not	recreated	
by	the	3T3-J2-conditioned	medium	culture,	in	which	cells	were	re-fed	every	two	days.	An	
interesting	future	experiment	could	demonstrate	this	conclusively	by	design	of	a	bioreactor	
system	in	which	epithelial	growth	medium	flows	across	3T3-J2	feeder	cells	in	one	chamber	
and	then	feeds	epithelial	cells	in	a	physically	separate	adjacent	chamber.	
	
Overall,	alternative	adult	human	feeder	cells	that	could	be	used	in	an	autologous	manner	in	
patients	were	unable	to	recapitulate	the	effect	of	3T3-J2	mouse	embryonic	feeder	cells	on	
the	growth	of	airway	basal	cells.	However,	expanding	epithelial	cells	from	endobronchial	
biopsies	and	brushing	samples	directly	in	3T3+Y,	rather	than	initially	in	BEGM	as	previously	
has	been	done,	allowed	a	further	reduction	in	epithelial	cell	culture	time.	Additionally,	a	
continuous	supply	of	3T3-J2	feeder	cell-secreted	factors	appeared	to	be	critical	for	the	
improvement	in	epithelial	cell	expansion.		
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Figure	5.5:	Colony-forming	experiments	reveal	that	a	secreted	factor	mediates	the	effects	of	3T3-J2	feeder	cells	
on	human	epithelial	cells.	A)	Representative	images	of	colony-forming	experiments	comparing	the	effect	of	3T3-
J2-conditioned	medium	(CM+Y),	co-culture	with	3T3-J2	feeder	cells	physically	separated	from	human	epithelial	
cells	by	a	transwell	system	and	direct	co-culture	of	3T3-J2	feeder	cells	and	human	epithelial	cells.	B)	Summary	
data	of	colony-forming	experiments	(3	donors	repeated	in	triplicate;	mean	+/-	SD).	Statistical	analysis	was	
performed	using	a	one-way	ANOVA	with	Bonferroni	post-test;	mean	+/-	SEM;	*	indicates	p	<	0.05;	***	p	=	0.001,	
****	p<0.0001;	n	=	6-13.	
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5.4 Summary	
	
• Feeder	layers	consisting	of	allogeneic	human	bone	marrow	MSCs	or	human	lung	
fibroblasts	do	not	successfully	recreate	the	co-culture	conditions	provided	by	3T3+Y.	
• Human	airway	basal	cells	can	be	expanded	by	plating	endobronchial	biopsy	samples	
directly	in	3T3+Y.	
• Plating	single	cell	suspensions	from	either	digested	endobronchial	biopsy	samples	or	
from	endobronchial	brushings	in	3T3+Y	expands	the	greatest	number	of	epithelial	
cells	in	the	shortest	time.	
• Although	the	remarkable	effects	of	3T3+Y	are	mediated	by	factors	secreted	by	3T3-
J2	fibroblasts,	3T3-J2-conditioned	medium	could	not	fully	recreate	the	effect	of	co-
culture.	
	
	
	
	
	
	
	
	
	
	
	
	
	
129	
 
	
	
	
			
6 .	Stromal-epithelial	crosstalk	
between	co-cultured	3T3-J2	
fibroblasts	and	primary	human	
basal	cells	
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6.1 Background	
	
Having	established	a	methodology	to	expand	large	numbers	of	primary	human	airway	
epithelial	cells	using	3T3-J2	co-culture,	I	sought	to	characterise	stromal-epithelial	cell	
interactions	during	co-culture	with	a	view	to	understanding	their	molecular	basis.	Data	from	
Chapter	5	show	that	3T3-J2	feeder	cells	mediate	their	effects	through	a	secreted	factor;	
however,	the	identity	of	this	factor(s)	remains	unclear.	Understanding	the	mechanisms	
underlying	the	effects	of	3T3-J2	co-culture	is	important	for	several	reasons.	First,	knowledge	
of	the	factor(s)	that	mediate	the	effects	of	3T3-J2	fibroblasts	would	offer	the	potential	to	
manufacture	a	medium	containing	the	relevant	factor(s)	and	to	use	this	instead	of	3T3-J2	co-
culture	to	expand	airway	epithelial	cells.	This	would	be	useful	for	epithelial	cell	research	in	
general	as	it	would	remove	the	need	to	maintain	3T3-J2s	and	to	differentially	trypsinise	
them	to	avoid	the	risk	of	them	contaminating	downstream	assays.	In	addition,	it	would	be	
really	useful	for	expanding	epithelial	cells	for	tissue-engineering	applications	as	replacing	the	
3T3-J2	feeder	layer	with	a	defined	medium	would	be	much	more	compliant	with	good	
manufacturing	practices.	Second,	understanding	how	3T3-J2	feeder	cells	confer	increased	
stem	cell	capacity	and	growth	potential	to	epithelial	cells	may	give	clues	as	to	the	
mechanisms	behind	stromal	and	epithelial	cell	crosstalk	in	vivo.	
	
Despite	many	decades	of	research	using	3T3-J2	co-culture	to	expand	human	epidermal	
keratinocytes	in	vitro	[190],	the	factor(s)	responsible	for	their	remarkable	effects	on	stem	
cell	maintenance	are	still	not	completely	understood	and	feeder-free	alternative	culture	
systems	are	still	not	able	to	replace	feeder	cells	using	defined	factors	[280].	I	sought	to	
characterise	the	nature	of	3T3-J2	support	for	primary	human	airway	basal	cells	and	to	
identify	factors	from	fibroblast	feeder	cells	that	affect	epithelial	cells.	While	not	prohibitive,	
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co-culture	with	xenogeneic	cells	is	not	ideal	for	clinical	translation	of	this	culture	system	and	
understanding	the	signalling	pathways	involved	might	allow	us	to	replace	co-culture	with	an	
equally	effective	defined	medium.			
6.2 Aims	
	
• To	investigate	the	receptors	that	are	activated	on	airway	epithelial	cells	in	response	
to	the	factors	secreted	by	3T3-J2	cells.	
• To	investigate	the	nature	of	feeder	cell	secretions	that	signal	to	airway	epithelial	
cells	in	co-culture.	
• To	identify	the	downstream	signalling	pathways	that	are	responsible	for	the	3T3-J2-
secreted	factor(s)’s	mode	of	action.	
• To	investigate	whether	the	growth	advantages	conferred	on	airway	epithelial	cells	
by	co-culture	with	3T3-J2	feeder	cells	can	be	reversed	by	inhibition	of	these	
signalling	pathways.	
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6.3 Results	
The	HGF	receptor,	MET,	is	activated	by	3T3-J2-conditioned	medium	
	
As	the	effects	of	3T3-J2	cells	appear	to	be	mediated	by	secreted	factors,	a	receptor	tyrosine	
kinase	activation	array	[281]	was	performed	on	primary	human	basal	epithelial	cells	
stimulated	with	medium	conditioned	by	3T3-J2	fibroblasts.	Strong	activation	of	the	
epidermal	growth	factor	receptor	(EGFR)	and	the	insulin-like	growth	factor	1	receptor	
(IGF1R)	was	observed	in	cells	stimulated	with	both	base	medium	and	conditioned	medium,	
consistent	with	the	inclusion	of	EGF	and	insulin	in	the	base	medium	(Figure	6.1A).	However,	
we	found	that	the	hepatocyte	growth	factor	receptor	(HGFR/MET)	was	strongly	activated	by	
conditioned	medium	but	not	by	base	medium	alone	(Figure	6.1A).	MET	activation	by	3T3-J2-
conditioned	medium	was	validated	by	western	blot,	analysing	three	phosphorylation	sites:	
tyrosine	1003	(Y1003),	which	leads	to	receptor	ubiquitination	and	recycling	via	endosomal	
pathways	[282],	and	Y1234/Y1235,	which	lies	within	the	activation	loop	of	MET’s	tyrosine	
kinase	domain,	were	strongly	phosphorylated,	while	Y1349,	an	autophosphorylation	site	
(Figure	6.1B)	that	generates	a	multisubstrate-docking	site	[283],	showed	less	marked	
phosphorylation	(Figure	6.1C).		
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Figure	6.1:	Activation	of	the	HGF	receptor,	MET,	by	3T3-J2-conditioned	medium.	A)	Receptor	tyrosine	kinase	
array	analysis	of	primary	human	airway	epithelial	cells	stimulated	for	30	minutes	with	3T3-J2	feeder	cell-
conditioned	medium.	Specific	activation	of	the	hepatocyte	growth	factor	(HGF)	receptor,	MET,	on	Y1234/Y1235	
was	observed	in	cells	stimulated	with	3T3-J2-conditioned	medium	both	in	the	presence	or	in	the	absence	of	Rho-
associated	protein	kinase	(ROCK)	inhibition	using	Y-27632.	B)	Schematic	representation	of	MET	receptor	
structure	showing	relevant	phosphorylation	sites.	C)	Western	blot	confirmation	in	independent	lysates	of	MET	
phosphorylation	following	stimulation	of	primary	human	airway	epithelial	cells	with	3T3-J2	feeder	cell-
conditioned	medium	for	30	minutes.	
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Having	established	that	MET	is	phosphorylated	in	response	to	3T3-J2-conditioned	medium,	I	
hypothesised	that	HGF,	the	ligand	for	MET,	may	be	the	3T3-J2-secreted	factor	that	confers	
increased	growth	potential	in	airway	epithelial	cells.	Consistent	with	HGF-mediated	crosstalk	
between	fibroblasts	and	epithelial	cells,	the	amount	of	HGF	secreted	into	culture	medium	by	
feeder	cells	increased	over	time	following	mitotic	inactivation	(Figure	6.2A)	and	the	amount	
of	HGF	mRNA	in	3T3-J2	cells	also	increased	during	the	first	24	hours	following	mitotic	
inactivation	(Figure	6.2B).	
	
	
	
Figure	6.2:	HGF	is	produced	by	3T3-J2	feeder	cells	following	mitotic	inactivation	but	does	not	affect	human	
airway	basal	cell	proliferation.	A)	ELISA	quantification	of	hepatocyte	growth	factor	(HGF)	secreted	into	culture	
medium	by	3T3-J2	feeder	cells	following	mitotic	inactivation	with	mitomycin	C	(MMC).	Medium	was	collected	
and	replaced	with	fresh	medium	after	24	and	48	hours	(n	=	4;	mean	+/-	SEM;	*	indicates	p	<	0.05,	**	indicates	p	<	
0.01).	B)	Quantification	of	HGF	mRNA	levels	in	3T3-J2	feeder	cells	following	mitotic	inactivation	with	mitomycin	
C.	(n	=	3;	mean	+/-	SEM).	C)	Flow	cytometric	analysis	of	EdU	uptake	in	primary	human	airway	epithelial	cells	
treated	with	either	epithelial	culture	medium	alone,	3T3-J2-conditioned	epithelial	growth	medium	or	the	same	
medium	containing	100	nM	PF-0421903,	a	small	molecule	MET	inhibitor	(n	=	3;	mean	+/-	SEM).	
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Murine	HGF	activates	intracellular	signalling	but	does	not	affect	basal	cell	proliferation	
	
Previous	work	suggests	that	murine	HGF	does	not	exert	biological	effects	in	human	cells	as	a	
result	of	a	failure	to	initiate	autophosphorylation	of	the	multisubstrate-docking	site	[284].	To	
investigate	whether	this	was	true	in	our	co-culture	system,	I	investigated	proliferation	of	
airway	epithelial	cells	by	analysing	EdU	incorporation.	3T3-J2-conditioned	medium	induced	
an	increase	in	the	proliferation	of	epithelial	cells	compared	with	medium	alone,	which	is	
consistent	with	data	in	Chapter	4	showing	that	3T3-J2	co-culture	increases	the	proliferation	
of	epithelial	cells.	Consistent	with	the	idea	that	murine	HGF	does	not	have	an	effect	in	
human	cells,	I	discovered	that	inhibition	of	MET,	using	the	small	molecule	MET	inhibitor	PF-
04217903	[248],	did	not	reduce	the	increased	epithelial	cell	proliferation	induced	by	3T3+Y-
conditioned	medium	(Figure	6.2C).		
	
However,	upon	investigation	of	the	phosphorylation	status	of	MET	downstream	effector	
proteins	such	as	focal	adhesion	kinase	(FAK;	Figure	6.3A)	and	GRB2-associated-binding	
protein	1	(GAB1;	Figure	6.3B),	I	identified	phosphorylation	sites	that	were	activated	by	3T3-
J2-conditioned	medium,	hinting	that	a	subset	of	intracellular	MET	signalling	events	might	
continue	as	a	result	of	stimulation	of	the	human	MET	receptor	with	murine	HGF.	Focal	
adhesion	kinase	was	not	investigated	further	as	the	phosphorylation	site	that	appeared	to	
be	activated	was	a	higher	molecular	weight	than	the	total	FAK	protein	(middle	band	in	
phospho-Y925	blot;	Figure	6.3A	and	6.3C).	I	was,	however,	able	to	identify	the	
phosphorylated	protein	apparent	in	GAB1	blots	as	the	related	adapter	protein	GAB2	(Figure	
6.3C);	a	finding	that	resulted	from	antibody	cross-reactivity.	As	GAB2	is	known	to	
phosphorylate	and	activate	the	transcription	factor	signal	transducer	and	activator	of	
transcription	6	(STAT6)	in	differentiated	airway	goblet	cells	[285],	the	phosphorylation	status	
of	STAT6	in	response	to	stimulation	with	3T3-J2-conditioned	medium	was	determined.	
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STAT6	was	robustly	phosphorylated	in	epithelial	cells	treated	with	conditioned	medium	with	
and	without	the	ROCK	inhibitor,	while	no	STAT6	phosphorylation	was	observed	in	cells	
treated	with	medium	only	(Figure	6.3C).	Importantly,	the	phosphorylation	events	of	FAK,	
GAB2	and	STAT6	were	reversible	by	inhibition	of	MET	using	PF-04217903	(Figure	6.3C),	
suggesting	that	HGF	is	the	factor	responsible	for	activation	of	these	proteins	and	that,	
although	it	is	not	responsible	for	the	increased	epithelial	cell	proliferation	induced	by	3T3-J2	
co-culture,	it	might	induce	some	functional	response	in	epithelial	cells.	
	
	
	
Figure	6.3:	Activation	of	signalling	pathways	downstream	of	MET	in	human	airway	epithelial	cells	following	
stimulation	with	3T3-J2-conditioned	medium.	A)	Western	blot	analysis	of	focal	adhesion	kinase	(FAK)	
phosphorylation	following	stimulation	of	human	airway	epithelial	cells	with	3T3-J2-conditioned	medium	for	30	
minutes.	B)	Western	blot	analysis	of	GRB2-associated-binding	protein	1	(GAB1)	phosphorylation	status	following	
stimulation	of	human	airway	epithelial	cells	with	3T3-J2-conditioned	medium	for	30	minutes.	C)	Western	blot	
analyisis	of	MET,	FAK,	GAB2	and	signal	transducer	and	activator	of	transcription	6	(STAT6)	phosphorylation	status	
following	stimulation	of	human	airway	epithelial	cells	with	3T3-J2-conditioned	medium	for	30	minutes	in	the	
presence	of	100	nM	PF-04217903,	a	small	molecule	MET	inhibitor.	
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Human	HGF	phosphorylates	STAT6	in	human	airway	basal	cells	
	
The	phosphorylation	events	described	above	could	be	explained	by	the	presence	of	co-
factors	in	conditioned	medium	or	by	the	non-physiological	action	of	murine	HGF	on	the	
human	MET	receptor.	To	address	this	point,	the	same	phosphorylation	sites	of	MET,	GAB2	
and	STAT6	were	investigated	in	cells	stimulated	with	recombinant	human	HGF.	All	sites	were	
phosphorylated,	including	the	autophosporylated	multisubstrate-docking	domain	that	was	
inefficiently	activated	by	murine	HGF	in	3T3-J2-conditioned	medium	(Figure	6.4A).	GAB2	and	
STAT6	activation	in	response	to	human	HGF	was	dependent	on	MET	as	PF-0421903	again	
prevented	their	activation	(Figure	6.4B).	Experiments	were	initially	performed	using	a	high	
concentration	of	50	ng/ml	HGF	but	a	titration	of	recombinant	HGF	concentration	revealed	
that	STAT6	was	phosphorylated	by	concentrations	of	HGF	above	5	ng/ml	(Figure	6.4C).	
Phosphorylation	of	MET,	GAB2	and	STAT6	was	maximal	around	30	minutes	following	
stimulation	with	HGF	and	was	sustained	for	approximately	8	hours	but	had	disappeared	by	
24	hours	(Figure	6.5).	Given	the	similarity	of	the	timecourses	for	MET,	GAB2	and	STAT6,	it	is	
likely	that	availability	of	recombinant	protein	in	the	medium	is	the	limiting	factor	causing	the	
cessation	of	signalling	(Figure	6.5).		
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Figure	6.4:	Phosphorylation	of	MET,	GAB2	and	STAT6	in	response	to	recombinant	human	HGF.	A)	Western	blot	
analysis	of	MET,	GRB2-associated-binding	protein	2	(GAB2)	and	signal	transducer	and	activator	of	transcription	6	
(STAT6)	phosphorylation	status	in	human	airway	epithelial	cells	stimulated	with	50	ng/ml	recombinant	human	
hepatocyte	growth	factor	(HGF)	for	30	minutes.	B)	Western	blot	analyisis	of	MET,	GAB2	and	STAT6	
phosphorylation	status	following	stimulation	of	human	airway	epithelial	cells	with	50	ng/ml	recombinant	human	
HGF	for	30	minutes	in	the	presence	of	100	nM	PF-04217903,	a	small	molecule	MET	inhibitor.	C)	Western	blot	
analysis	of	STAT6	phosphorylation	status	in	response	to	various	doses	of	recombinant	human	HGF	for	30	
minutes.	
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Figure	6.5:	Timecourse	of	MET,	GAB2	and	STAT6	phosphorylation	in	human	airway	epithelial	cells	in	response	
to	recombinant	human	HGF.	A)	Western	blot	analysis	of	the	phosphorylation	status	of	MET	over	time	following	
stimulation	with	50	ng/ml	recombinant	human	hepatocyte	growth	factor	(HGF).	B)	Western	blot	analysis	of	the	
phosphorylation	status	of	GRB2-associated-binding	protein	2	(GAB2)	over	time	following	stimulation	with	50	
ng/ml	recombinant	human	HGF.	C)	Western	blot	analysis	of	the	phosphorylation	status	of	signal	tranducer	and	
activator	of	transcription	6	(STAT6)	over	time	following	stimulation	with	50	ng/ml	recombinant	human	HGF.	
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HGF-induced	STAT6	phosphorylation	is	not	dependent	on	GAB2	
	
Although	cooperation	between	interleukin-4	(IL-4)/IL-13-driven	STAT6	activation	and	MET	
signalling	has	previously	been	shown	[286],	the	direct	activation	of	STAT6	in	response	to	
HGF	is	novel	so	I	next	examined	the	mechanism	of	STAT6	activation.	A	previous	report	that	
GAB2	phosphorylates	STAT6	downstream	of	IL-13	in	airway	epithelia	[285]	prompted	the	
investigation	of	a	MET-GAB2-STAT6	pathway,	in	which	MET	phosphorylates	GAB2,	which	
results	in	the	phosphorylation	of	STAT6.	I	used	siRNA	to	knock	down	GAB2	in	airway	
epithelial	cells.	3	nM	siRNA	caused	some	knowndown	of	GAB2	compared	with	non-silencing	
siRNA,	but	expression	was	almost	entirely	knocked	down	with	5	nM	siRNA	(Figure	6.6A)	so	
this	concentration	with	used	for	subsequent	studies.	Interestingly,	knockdown	of	GAB2	using	
siRNA	did	not	affect	MET-induced	STAT6	activation	(Figure	6.6B),	suggesting	that	
phosphorylation	of	STAT6	is	not	dependent	on	GAB2.		
	
As	STAT3	binds	directly	to	the	MET	receptor	via	its	SH2	domain	[287,	288]	and	STAT6	also	
contains	an	SH2	domain	[289],	co-immunoprecipitation	experiments	were	performed	to	
determine	whether	STAT6	binds	to	MET	following	the	phosphorylation	induced	by	
stimulation	with	HGF.	Successful	pull-down	of	MET	was	achieved,	as	MET	can	clearly	be	seen	
in	the	immunoprecipitation	fraction	but	not	in	the	supernatant.	However,	neither	STAT6	nor	
phosphorylated	STAT6	could	be	detected	in	MET	pull-downs	(Figure	6.6C),	suggesting	that	
no	complex	of	MET	and	STAT6	exists	following	stimulation	with	HGF.	
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Figure	6.6:	Investigation	of	the	mechanism	of	HGF-induced	STAT6	phosphorylation	in	human	airway	epithelial	
cells.	A)	Western	blot	analysis	showing	knockdown	of	GRB2-associated-binding	protein	2	(GAB2)	using	5	nM	anti-
GAB2	siRNA	compared	with	non-silencing	RNA.	α-tubulin	was	used	as	a	loading	control.	B)	Western	blot	analysis	
of	signal	transducer	and	activator	of	transcription	6	(STAT6)	phosphorylation	status	in	cells	treated	with	either	5	
nM	non-silencing	siRNA	or	5	nM	anti-GAB2	siRNA.	Unstimulated	primary	human	airway	epithelial	cells	were	
compared	to	matched	cells	stimulated	with	50	ng/ml	recombinant	human	hepatocyte	growth	factor	(HGF).	C)	
Western	blot	analysis	of	co-immunoprecipitation	experiment.	Unstimulated	primary	human	airway	epithelial	
cells	were	compared	to	matched	cells	stimulated	with	10	ng/ml	recombinant	human	HGF.	MET	was	
immunoprecipitated	using	Dynabeads	and	the	supernatant	retained.	STAT6	was	not	co-immunoprecipitated	with	
MET	but	was	instead	found	in	the	unbound	protein	fraction.	
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HGF	promotes	GM-CSF	and	IL-8	secretion	from	human	airway	basal	cells		
	
As	STAT6	controls	the	transcriptional	response	of	epithelial	cells	following	stimulation	with	
IL-4	or	IL-13	[290],	the	effect	of	HGF-induced	STAT6	signalling	on	airway	basal	cell	cytokine	
secretion	was	analysed	using	an	array	panel.	Increased	secretion	of	the	neutrophil	
chemoattractants	granulocyte/macrophage	colony-stimulating	factor	(GM-CSF)	and	IL-8	
[291,	292]	was	found	following	stimulation	with	HGF	(Figure	6.7A).	Interestingly,	baseline	
secretion	was	restored	in	the	presence	of	the	MET	inhibitor	PF-0421903	or	the	STAT6	small	
molecule	inhibitor	AS-1517499	(Figure	6.7A)	[293,	294].	These	results	were	confirmed	by	
ELISA	in	additional	human	donor	cell	cultures	and	the	same	pattern	of	secretion	was	
observed	(Figure	6.7B).	At	the	level	of	gene	expression,	HGF	treatment	of	serum-starved	
human	airway	basal	cells	causes	upregulation	of	transcription	of	both	GM-CSF	(Figure	6.7C)	
and	IL-8	(Figure	6.7D)	and	STAT6	inhibition	appeared	to	cause	a	dose-dependent	decrease	in	
the	expression	of	both	of	these	genes	(Figure	6.7C	and	6.7D).	Taken	together,	these	results	
suggest	that	phosphorylation	of	MET	and	STAT6	following	stimulation	with	HGF	induces	an	
increase	in	the	expression	and	secretion	of	IL-8	and	GM-CSF.	
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Figure	6.7:	HGF	causes	an	increase	in	the	transcription	and	the	secretion	of	GM-CSF	and	IL-8	in	cultured	human	
airway	epithelial	cells.	A)	Cytokine	array	analysis	of	primary	human	airway	epithelial	cells	stimulated	with	either	
vehicle	control,	10	ng/ml	recombinant	human	hepatocyte	growth	factor	(HGF),	10	ng/ml	recombinant	human	
HGF	and	250	nM	PF-04217903	(a	MET	inhibitor)	or	10	ng/ml	recombinant	human	HGF	and	10	μM	AS-1517499	(a	
STAT6	inhibitor).	B)	ELISA	quantification	of	granulocyte/macrophage	colony-stimulating	factor	(GM-CSF;	upper)	
and	interleukin-8	(IL-8;	lower)	secretion	into	culture	medium	in	independent	primary	human	airway	epithelial	cell	
cultures	stimulated	with	either	vehicle	control,	10	ng/ml	recombinant	human	HGF,	10	ng/ml	recombinant	human	
HGF	and	250	nM	PF-04217903	or	10	ng/ml	recombinant	human	HGF	and	10	μM	AS-1517499	(n	=	4-9	donors;	
mean	+/-	SEM).	Statistical	analysis	was	performed	using	a	one-way	ANOVA	(with	Bonferroni’s	post-test)	
comparing	each	group	with	HGF-treated	cells;	**	indicates	p	<	0.01,	***	indicates	p	<	0.001.	C)	qPCR	
quantification	of	GM-CSF	gene	expression	in	primary	human	airway	epithelial	cells	following	stimulation	with	10	
ng/ml	recombinant	human	HGF	and	various	doses	of	AS-1517499	(n	=	1	donor	performed	in	technical	triplicate;	
mean	+/-	SEM).	D)	qPCR	quantification	of	IL-8	gene	expression	in	primary	human	airway	epithelial	cells	following	
stimulation	with	10	ng/ml	recombinant	human	HGF	and	various	doses	of	AS-1517499	(n	=	1	donor	performed	in	
technical	triplicate;	mean	+/-	SEM).	
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HGF-induced	IL-8	expression	is	STAT6	independent	
	
To	confirm	that	induction	of	STAT6-dependent	transcription	is	indeed	induced	by	HGF	
stimulation,	I	established	a	luciferase	reporter	assay.	As	reporter	assays	are	well	established	
in	cancer	cell	lines	in	our	laboratory,	the	utility	of	using	cancer	cell	lines	as	a	system	to	study	
HGF-dependent	STAT6-dependent	transcription	was	investigated.	HGF	caused	STAT6	
phosphorylation	in	both	A549	(lung	adenocarcinoma)	and	A431	(epidermoid	carcinoma)	
cancer	cell	lines	but	did	not	phosphorylate	STAT6	in	human	lung	fibroblasts	(Figure	6.8A);	
these	were	included	as	a	control	due	to	their	lack	of	expression	of	the	HGF	receptor	MET	
[295].	These	results	show	that	HGF-dependent	STAT6	phosphorylation	is	not	restricted	to	
primary	airway	epithelial	cells	but	is	also	true	for	at	least	A549	and	A431	cancer	cell	lines.	
These	results	also	suggested	that	a	cancer	cell	line	could	be	used	to	further	investigate	
STAT6-dependent	transcription	instead	of	primary	airway	epithelial	cells.	To	do	so,	a	STAT6	
consensus	sequence	luciferase	reporter	vector	–	p4xSTAT6-Luc2P	–	was	used.	This	construct	
contains	four	tandem	repeats	of	STAT6/cEBP-binding	sites	(TTCN4GAA)	from	the	human	
germline	ε	promoter	sequence	upstream	of	the	luciferase	gene.	A431	cells	transfected	with	
this	STAT6	luciferase	reporter	plasmid	were	incubated	with	either	a	vehicle	control,	50	
ng/ml	recombinant	human	HGF	or	50	ng/ml	recombinant	human	IL-13,	which	was	used	as	a	
positive	control	given	that	IL-13	is	known	to	have	a	role	in	activating	STAT6-dependent	
transcription	in	epithelial	cells	[59,	296].	After	3	hours,	the	activity	of	the	luciferase	reporter	
was	assayed	using	a	luminometer.	Results	showed	that	stimulation	of	cells	with	IL-13	
induced	strong	expression	of	luciferase,	while	recombinant	human	HGF	had	no	effect	on	the	
expression	of	luciferase	(Figure	6.8B),	indicating	that	HGF	does	not	activate	STAT6-
dependent	transcription	at	this	time	point.	To	ensure	that	HGF-induced	STAT6	transcription	
does	not	occur	at	an	earlier	time	point,	this	experiment	was	repeated	at	four	earlier	time	
points.	IL-13	induced	luciferase	expression	after	15	minutes	but	no	induction	of	luciferase	
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expression	was	seen	in	response	to	HGF	stimulation	in	any	of	the	time	points	investigated	
(Figure	6.8C).	
	
	
Figure	6.8:	Establishment	of	a	firefly	luciferase	STAT6	reporter	assay	in	A431	cancer	cells.	A)	Western	blot	
analysis	of	STAT6	phosphorylation	in	the	A549	cancer	cell	line,	the	A431	cancer	cell	line	and	primary	human	lung	
fibroblasts	following	stimulation	with	50	ng/ml	recombinant	human	hepatocyte	growth	factor	(HGF).	B)	
Quantification	of	firefly	luciferase	STAT6	reporter	activity	using	luminescence	in	A431	cancer	cells	treated	for	3	
hours	with	either	a	vehicle	control,	50	ng/ml	recombinant	human	HGF	or	50	ng/ml	recombinant	human	
interleukin-13	(IL-13).	Values	were	normalised	according	to	expression	of	a	constitutively	active	renilla	luciferase	
in	order	to	account	for	variation	in	transfection	efficiency.	Statistical	analysis	comparing	vehicle	and	HGF-	or	IL-
13-treated	groups	was	performed	using	a	one-way	ANOVA	with	Bonferroni	post-test;	n	=	6	(mean	+/-	SEM);	****	
indicates	P<0.0001.	C)	Quantification	of	firefly	luciferase	reporter	STAT6	activity	using	luminescence	in	A431	
cancer	cells	treated	for	15	minutes,	30	minutes,	45	minutes	or	2	hours	with	either	a	vehicle	control,	50	ng/ml	
recombinant	human	HGF	or	50	ng/ml	recombinant	human	IL-13.	Values	were	normalised	according	to	expression	
of	a	constitutively	active	renilla	luciferase	in	order	to	account	for	variation	in	transfection	efficiency.	Statistical	
analysis	comparing	vehicle	and	HGF-	or	IL-13-treated	groups	was	performed	using	a	two-way	ANOVA	with	
Bonferroni	post-test;	n	=	3	(mean	+/-	SEM);	unlabelled	bars	were	not	statistically	significant,	****	indicates	
P<0.0001.	
	
	
146	
 
These	experiments	contradicted	earlier	findings	because	STAT6	is	robustly	phosphorylated	
at	Y641,	the	site	associated	with	its	dimerisation	and	translocation	into	the	nucleus	(that	is,	
the	activating	phosphorylation	site)	[297],	in	response	to	HGF	but	does	not	activate	STAT6-
dependent	transcription.	In	order	to	better	understand	what	was	happening,	subcellular	
fractionation	was	established	to	cleanly	resolve	cytoplasmic	and	nuclear	proteins	(Figure	
6.9A).	This	technique	was	then	used	to	determine	the	location	of	STAT6	within	cells	
following	stimulation	with	either	HGF	or	IL-13.	This	experiment	revealed	that	either	30	
minutes	(Figure	6.9B)	or	2	hours	(Figure	6.9C)	following	stimulation,	STAT6	was	found	in	the	
nucleus	of	cells	stimulated	with	IL-13	but	remained	in	the	cytoplasm	of	cells	stimulated	with	
HGF.	Despite	the	presence	of	protease	and	phosphatase	inhibitors,	phosphorylated	STAT6	
was	not	detected	well	in	these	assays,	presumably	due	to	the	different	buffers	used	to	
process	protein	samples	for	subcellular	fractionation	but	results	for	total	STAT6	protein	were	
conclusive.	Interestingly,	some	STAT6	protein	was	seen	in	the	nucleus	of	unstimulated	cells,	
which	is	consistent	with	the	fact	that	STAT6	is	continually	imported	and	exported	out	of	the	
nucleus,	independently	of	its	phosphorylation	status	[298].	However,	these	results	mean	
that	it	is	unlikely	that	the	inhibition	of	GM-CSF	and	IL-8	transcription	seen	previously	with	
AS-1517499	is	caused	by	on-target	effects	on	STAT6	and	suggest	that	induction	of	GM-CSF	
and	IL-8	transcription	in	response	to	HGF	is	not	STAT6	dependent.	Indeed,	these	results	
suggest	that	alternative	pathways	are	induced	by	HGF	to	cause	GM-CSF	and	IL-8	
transcription.	
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Figure	6.9:	HGF	causes	the	phosphorylation	but	not	the	nuclear	translocation	of	STAT6.	A)	Western	blot	analysis	
of	MEK1/2	(cytoplasmic)	and	histone	H3	(nuclear	and	chromatin	bound)	in	lysates	processed	using	a	subcellular	
fractionation	kit	to	confirm	that	cytoplasmic,	nuclear	and	chromatin-bound	protein	fractions	were	obtained.	B)	
Western	blot	analysis	of	signal	transducer	and	activator	of	transcription	6	(STAT6)	phosphorylation	status	in	
primary	human	airway	epithelial	cells	treated	with	either	hepatocyte	growth	factor	(HGF)	or	interleukin-13	(IL-
13)	for	30	minutes.	Whole	cell	lysates	were	obtained	using	RIPA	buffer	and	compared	with	independent	lysates	
prepared	using	a	subcellular	fractionation	kit.	C)	Western	blot	analysis	of	STAT6	phosphorylation	status	in	
primary	human	airway	epithelial	cells	treated	with	either	HGF	or	IL-13	for	2	hours.	
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Although	results	in	Figure	6.9	suggest	that	induction	of	GM-CSF	and	IL-8	expression	in	
response	to	HGF	stimulation	is	not	mediated	by	STAT6,	previous	experiments	showed	a	
downregulation	of	both	GM-CSF	and	IL-8	protein	(Figure	6.7A	and	6.7B)	and	gene	expression	
(Figure	6.7C	and	6.7D)	by	the	STAT6	small	molecule	inhibitor	AS-1517499	following	HGF	
stimulation.	To	reconcile	these	results,	western	blots	were	performed	to	investigate	the	
phosphorylation	status	of	MET	and	STAT6	in	response	to	the	5	μM	dose	of	AS-1517499	used	
in	those	experiments.	These	results	show	that	MET	phosphorylation	itself	is	reduced	by	AS-
1517499,	suggesting	that	an	off-target	effect	of	this	drug	might	be	responsible	for	its	
apparent	effect	on	GM-CSF	and	IL-8	expression,	again	indicating	that	the	HGF-mediated	
induction	of	GM-CSF	and	IL-8	expression	and	secretion	in	epithelial	cells	is	not	dependent	on	
STAT6.	
	
	
Figure	6.10:	Non-specific	inhibition	of	MET	by	the	STAT6	inhibitor	AS-1517499.	Western	blot	analysis	of	MET	
and	signal	transducer	and	activator	of	transcription	6	(STAT6)	phosphorylation	status	in	primary	human	airway	
epithelial	cells	treated	with	a	vehicle	control,	50	ng/ml	recombinant	human	hepatocyte	growth	factor	(HGF)	or	50	
ng/ml	recombinant	human	HGF	and	5	μM	AS-1517499	(a	STAT6	inhibitor).	
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In	order	to	investigate	the	requirements	for	IL-8	transcription	in	response	to	HGF,	luciferase	
reporter	constructs	containing	the	IL-8	promoter	were	obtained.	These	plasmids	include	
different	lengths	of	the	IL-8	promoter	sequence	such	that	the	transcription	factor-binding	
sites	mediating	transcriptional	activation	can	be	inferred	[249,	250].	The	-2000	construct	
includes	IL-8	transcriptional	regulatory	elements	including	a	STAT6	consensus	sequence	
found	1850	bp	upstream	of	the	transcription	start	site	[250].	Two	truncated	versions	of	this	
upstream	region	were	analysed	to	tease	out	the	transcriptional	sites	that	mediate	HGF-
induced	IL-8	transcription	(Figure	6.11A).	The	-1400	plasmid	lacks	the	STAT6-binding	site	but	
contains	T-cell	factor/lymphoid	enhancer	factor	(TCF/LEF)-,	interferon-regulatory	factor	1	
(IRF1)-,	hepatocyte	nuclear	factor	1	(HNF1)-	and	glucocorticoid	receptor	(GR)-binding	sites	
that	are	absent	from	the	short	-173	sequence,	which	contains	activator	protein	1	(AP-1)-	and	
nuclear	factor-κB	(NF-κB)-binding	domains	(Figure	6.11B).	Upon	receipt	of	the	plasmids	from	
collaborators	the	inserts	were	checked	by	restriction	enzyme	digests,	which	demonstrated	
excised	fragments	of	the	predicted	molecular	weights	(Figure	6.11C).	A	luciferase	reporter	
assay	using	these	plasmids	showed	that	only	stimulation	of	A431	cells	transfected	with	the	-
173	IL-8	promoter	sequence	caused	upregulation	of	luciferase	activity	following	stimulation	
with	HGF	(Figure	6.11D).	This	result	suggests	that	proximal	transcription	factors	such	as	NF-
κB	and/or	AP-1,	which	are	known	to	respond	to	MET	activation	[299,	300],	rather	than	
STAT6,	are	candidate	transcription	factors	responsible	for	the	upregulation	of	IL-8	in	primary	
human	airway	epithelial	cells.	Interestingly,	they	also	suggest	a	possible	repressive	role	for	
more	distal	transcriptional	regulation	in	this	process	because	although	the	-2000	and	-1400	
constructs	contain	the	proximal	sites,	they	did	not	respond	significantly	to	HGF	stimulation	
(Figure	6.11D).	
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Figure	6.11:	HGF-induced	IL-8	transcription	is	mediated	by	NF-κB	rather	than	by	STAT6.	A)	Schematic	
representation	of	interleukin-8	(IL-8)	promoter	sequence	firefly	luciferase	reporter	constructs.	B)	Detailed	
schematic	representation	of	the	proximal	promoter	elements	of	IL-8.	C)	Validation	of	IL-8	promoter	sequence	
plasmids	by	NotI	and	XhoI	restriction	enzyme	digest.	D)	Quantification	of	firefly	luciferase	IL-8	promoter	reporter	
activity	using	luminescence	in	A431	cancer	cells	treated	for	30	minutes	with	either	a	vehicle	control	or	50	ng/ml	
recombinant	human	hepatocyte	growth	factor	(HGF).	Values	were	normalised	according	to	expression	of	a	
constitutively	active	renilla	luciferase	in	order	to	account	for	variation	in	transfection	efficiency.	Statistical	
analysis	comparing	vehicle	and	HGF-treated	groups	was	performed	using	a	two-way	ANOVA	with	Bonferroni	
post-test;	n	=	3	(mean	+/-	SEM);	****	indicates	P<0.0001.	
	
151	
 
To	conclude,	murine	HGF	partially	activates	the	human	MET	receptor	but	does	not	induce	
the	increased	proliferation	that	might	be	expected	in	human	cells.	However,	
phosphorylation	of	some	substrates	downstream	of	MET,	including	GAB2	and	the	novel	MET	
target	STAT6,	occurs	in	response	to	both	murine	and	human	HGF.	Human	HGF	also	leads	to	
phosphorylation	of	STAT6	downstream	of	the	MET	receptor	but	the	functional	relevance	of	
this	phosphorylation	was	not	established	as	MET	activation	does	not	lead	to	transcriptional	
activation	of	STAT6-target	genes.	Furthermore,	HGF-mediated	upregulation	of	IL-8	was	not	
dependent	on	STAT6.			
6.4 Summary	
	
• Our	3T3-J2	co-culture	system	was	used	to	investigate	stromal-epithelial	cell	
interactions.		
• HGF	secreted	from	fibroblasts	activates	MET	on	human	airway	basal	cells.		
• MET	activation	leads	to	STAT6	phosphorylation	but	not	to	transcriptional	activation	
of	STAT6-target	genes.	
• MET	signalling	leads	to	the	secretion	of	the	potent	neutrophil	chemoattractants	IL-8	
and	GM-CSF.	HGF-induced	IL-8	transcription	occurs	independently	of	STAT6.	
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7 .	Conclusions	and	future	
directions	
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Limitations	of	traditional	airway	epithelial	cell	culture	systems	
	
The	initial	aim	of	this	thesis	was	to	investigate	the	suitability	of	protocols	for	human	airway	
epithelial	cell	expansion	for	high-throughput	in	vitro	assays	relevant	to	drug	screening,	
toxicology	studies	and	personalised	medicine	[203]	and	for	airway	tissue-engineering	
applications	[77].	Consistent	with	previous	studies,	epithelial	cells	expanded	from	bronchial	
biopsy	samples	using	the	established	protocol	for	airway	epithelial	cell	expansion,	bronchial	
epithelial	growth	medium	(BEGM),	expressed	basal	stem	cell	markers	[301]	and	were	
capable	of	differentiation	at	very	early	passages	[222,	223].	However,	a	key	early	finding	was	
that	this	protocol	was	largely	unsuitable	for	our	target	studies.		
	
BEGM	protocols	were	initially	developed	using	large	cadaveric	airway	tissue	samples	[222]	
and	in	this	work	I	showed	that,	even	when	cultures	are	initiated	from	the	large	numbers	of	
airway	epithelial	cells	that	would	be	supplied	by	these	samples,	they	are	limited	by	
diminishing	proliferation	over	passage	and	by	eventual	senescence	or	terminal	
differentiation	in	these	conditions	[49,	117,	265,	267].	Previous	studies	demonstrate	that	the	
capacity	of	cultured	basal	cells	to	regenerate	ciliated	epithelium	declines	as	a	function	of	
population	doubling	number	[265].	Here,	as	cells	were	cultured	from	living	patients	through	
isolation	of	cells	from	endobronchial	biopsy	samples,	the	starting	material	necessarily	
contained	a	tiny	fraction	of	the	basal	epithelial	stem/progenitor	cells	obtained	from	whole	
airway	samples.	In	these	studies,	the	capacity	of	human	basal	cells	to	form	either	air-liquid	
interface	differentiated	epithelium	or	differentiated	three-dimensional	(3D)	tracheospheres	
was	compromised	after	four	passages	of	BEGM	culture,	suggesting	that	the	issue	of	limited	
proliferation,	in	vitro	senescence	and	loss	of	differentiation	capacity	in	passaged	cells	might	
be	exacerbated	by	the	limited	starting	material	in	biopsy-derived	cultures.	Indeed,	previous	
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descriptions	of	such	cultures	have	mainly	focused	on	the	initiation	of	basal	cell	culture	and	
the	earliest	passages	[219-221].	
	
Improved	airway	epithelial	cell	culture	using	3T3+Y	
	
The	work	presented	here	furthers	previous	research	in	which	epithelial	cells	have	been	
cultured	on	3T3-J2	feeder	cells	[189]	and	more	recently	using	this	culture	system	in	the	
presence	of	Rho-associated	protein	kinase	(ROCK)	inhibitors	[264].	While	the	ability	to	
expand	and	differentiate	airway	basal	cells	in	this	system	was	previously	shown	[264],	this	is	
first	detailed	characterisation	of	the	nature	of	basal	cells	expanded	using	the	combination	of	
mitotically	inactivated	murine	embryonic	fibroblast	feeder	layers	and	ROCK	inhibition	using	
Y-27632	(3T3+Y).	Further,	this	thesis	demonstrates	the	feasibility	of	expanding	basal	cells	
directly	from	primary	human	tissue	in	these	conditions	and	shows	that	replacement	of	3T3-
J2	cells	with	cells	that	can	be	derived	in	an	autologous	manner,	such	as	lung	fibroblasts	or	
bone	marrow-derived	mesenchymal	stem	cells	(MSCs),	is	not	successful.	
	
The	use	of	3T3+Y	culture	conditions	overcame	the	problems	associated	with	culture	in	
BEGM	and	allowed	the	expansion	of	meaningful	cell	numbers	from	small	biopsies	with	a	
high	success	rate.	This	is	important	for	a	number	of	reasons.	Firstly,	this	culture	technique	
will	provide	an	important	alternative	for	studying	airway	epithelial	cells	cultured	from	
different	patients.	Currently,	these	studies	are	limited	by	the	cost	of	commercial	primary	
cells	and	their	limited	lifespan	in	culture.	Additionally,	the	high	degree	of	inter-individual	
variability	seen	in	studies	using	human	airway	epithelial	cells	means	that	experiments	ideally	
require	investigation	of	a	range	of	donor	cell	cultures.	3T3+Y	expansion	and	
cryopreservation	of	primary	cells	that	retain	their	characteristics	for	longer	culture	periods	
might	enable	serial	investigation	of	the	same	donor	cell	cultures	and	might	improve	the	
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reliability	of	such	investigations.	Secondly,	endobronchial	biopsies	are	the	route	of	tissue	
acquisition	in	patients	receiving	epithelial	cell	therapy	as	part	of	tracheal	transplantation	
procedures	[70]	and,	given	the	high	number	of	epithelial	cells	required	for	successful	
scaffold	seeding	[302],	BEGM-based	strategies	would	require	a	number	of	biopsies	that	is	
clinically	unachievable,	particularly	as	patients	requiring	tissue-engineered	airway	
replacement	are	likely	to	have	severely	damaged	airway	epithelium.	3T3+Y	culture	
conditions	overcome	this	problem,	generating	clinically	useful	numbers	of	cells	that	retain	
their	differentiation	capacity	from	a	single	biopsy	sample.	Finally,	the	culture	of	cells	from	
living	patients	using	a	minimally	invasive	technique	suggests	the	application	of	these	
protocols	in	the	expanding	area	of	personalised	medicine	[303].	In	future,	airway	biopsies	
from	patients	with	respiratory	disease	could	be	expanded	in	3T3+Y	culture	and	therapies	
could	be	tested	for	their	in	vitro	efficacy	in	a	patient-specific	manner	and	used	to	inform	
clinical	decision-making.	It	will	be	interesting	to	establish	whether	disease-specific	basal	cells	
retain	their	characteristics	in	diseases	such	as	asthma	and	chronic	obstructive	pulmonary	
disease	(COPD).	Additionally,	the	expansion	of	primary	lung	tumour	cells	in	3T3+Y	and	the	
characterisation	of	the	extent	to	which	these	mimic	the	heterogeneity	[304]	and	the	
response	to	therapy	of	patient	tumours	will	be	of	interest	[305].	In	this	setting,	the	high	
success	rate	of	epithelial	cultures	in	3T3+Y	will	be	of	particular	importance	as	samples	may	
only	be	available	to	researchers	on	one	occasion.	
	
Effects	of	combined	3T3+Y	co-culture	on	cultured	human	airway	epithelial	cells	
	
In	an	attempt	to	understand	the	mechanism	of	action	of	3T3+Y,	using	microarray	and	
pathway	analysis,	key	pathways	were	identified	that	are	changed	in	airway	epithelial	cells	
grown	in	3T3+Y.	These	include	cell	cycle	regulators,	consistent	with	the	increased	
proliferation	of	cells	in	3T3+Y,	oxidative	stress	pathway	genes,	which	may	be	of	significance	
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given	that	reactive	oxygen	species	modulate	human	basal	cell	behaviour	through	NRF2	[306]	
and	neuregulin	signalling,	consistent	with	a	previous	report	that	feeder	cells	cause	
epidermal	growth	factor	receptor	(EGFR)	and	human	epidermal	growth	factor	receptor	2	
(HER2)	phosphorylation	in	epidermal	keratinocytes	[307].	Additionally,	telomerase	signalling	
genes	were	significantly	affected	by	co-culture.	Although	human	telomerase	reverse	
transcriptase	(TERT)	is	not	typically	expressed	in	somatic	cells,	low	expression	levels	are	
thought	to	slow	telomere	shortening	in	adult	stem	cells	[308]	and	exogenous	addition	of	
TERT	mRNA	extends	telomeres	and	the	lifespan	of	epidermal	keratinocytes	in	vitro	[309].	
Indeed,	work	from	another	member	of	the	laboratory	suggests	that,	while	telomere	lengths	
decrease	over	passage	in	BEGM,	telomeres	are	maintained	in	3T3+Y	[310],	suggesting	that	
this	might	be	one	reason	for	the	maintenance	of	stem	cell	capacity	in	these	culture	
conditions.	Although	consistent	with	the	behaviour	of	cells	cultured	in	3T3+Y,	the	array	data	
give	little	mechanistic	insight	into	the	molecular	basis	of	the	effects	of	3T3+Y.	Future	
mechanistic	studies	are	required	to	investigate	the	molecular	basis	of	airway	epithelial	cell	
expansion	in	3T3+Y	and	also	to	develop	protocols	for	clinical	airway	epithelial	cell	expansion	
that	are	not	dependent	on	murine	cells.	
	
Potential	roles	of	3T3-J2	feeder	cells	in	3T3+Y	
	
3T3-J2	co-culture	as	a	method	to	expand	human	epithelial	cells	was	first	described	by	Prof.	
Howard	Green	and	colleagues	in	1975	[188,	189],	and	expansion	of	epithelial	cells	from	a	
range	of	non-epidermal	organs,	including	the	oesophagus	[311],	intestines	[312]	and	lungs	
[313],	has	since	been	described.	However,	the	specific	contribution	of	3T3-J2	feeder	cells	has	
never	been	determined	and,	as	such,	clinical	products	involving	epidermal	and	limbal	
epithelial	stem	cell	expansion	remain	dependent	on	these	murine	feeder	cells	as	effective	
defined	media	alternatives	are	not	available.	
157	
 
Data	presented	here	suggest	that	a	continual	supply	of	soluble	feeder	cell	products	is	
required	by	epithelial	cells	for	optimal	expansion	because	co-culture	levels	of	epithelial	
support	were	recreated	in	colony	formation	assays	when	feeder	cells	were	separated	from	
epithelial	cells	by	a	transwell	membrane	but	not	when	feeder	cell-conditioned	medium	was	
delivered	three	times	per	week.	This	is	in	agreement	with	previous	observations	that	
epidermal	keratinocytes	are	not	supported	by	3T3-J2-conditioned	medium	[189,	314]	but	
contradicts	data	showing	that	separation	with	a	nitrocellulose	membrane	prevents	the	
keratinocyte-stimulating	effect	of	inactivated	3T3-J2	cells	[314].	The	association	of	the	
keratinocyte-stimulating	effect	of	3T3-J2	cells	with	the	membrane	of	3T3-J2	cells	[314]	
suggests	that	different	mechanisms	of	action	may	exist	in	different	epithelial	cell	types	as	
physical	separation	did	not	decrease	colony	formation	in	airway	epithelial	cell	co-cultures.			
	
I	have	shown	that	the	supportive	effects	of	3T3-J2	fibroblasts	cannot	be	recapitulated	by	
mitotically	inactivated	human	lung	fibroblast	or	human	mesenchymal	stromal	cell	feeder	
layers	[310],	which	could	be	used	in	an	autologous	manner	in	tissue-engineering	
applications.	These	investigations,	however,	cannot	rule	out	that	human	embryonic	
fibroblast	cell	lines,	such	as	MRC-5,	might	be	able	to	recapitulate	the	effects	of	3T3-J2	feeder	
cells	or	that	non-inactivated	stromal	cells	from	human	lungs	might	recapitulate	the	lung	
microenvironment	ex	vivo.		
	
Despite	the	existence	of	cell	therapies	that	use	3T3-J2-co-cultured	human	cells	[190,	194-
196,	198,	199],	future	work	will	establish	the	appropriate	feeder-free	culture	conditions	for	
human	airway	basal	cells.	This	is	likely	to	involve	better	characterisation	of	the	complex	
protein	(and	non-protein)	secretions	of	feeder	cells	as	they	undergo	apoptosis	[278],	the	
mode	of	their	delivery	(for	example,	secreted	protein,	extracellular	vesicles	or	another	
mechanism)	and	the	optimisation	of	culture	systems	to	deliver	these	in	vitro.	
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Potential	roles	of	the	ROCK	inhibitor	Y-27632	in	3T3+Y	
	
The	results	presented	here	show	that	addition	of	Y-27632	dramatically	improves	airway	
epithelial	cell	cultures	in	the	presence	of	3T3-J2	feeder	cells,	consistent	with	previous	
findings	that	Y-27362	increases	the	proliferation	and	the	lentiviral	transduction	efficacy	of	
mouse	and	human	airway	basal	cells	in	culture	[315].	While	the	effect	of	culture	using	
alternative	ROCK	inhibitors	has	not	been	investigated	here,	it	is	likely	that,	at	concentrations	
of	less	than	10	μM,	the	effects	observed	using	Y-27632	are	as	a	result	of	specific	inhibition	of	
ROCK1	and/or	ROCK2	in	airway	epithelial	cells	rather	than	as	a	result	of	an	off-target	effect	
on	proteins	such	as	PRK2	and	MSK1	[316]	Indeed,	in	epidermal	keratinocytes,	Y-27632	can	
be	replaced	by	fasudil	hydrochloride	(HA-1077;	inhibits	ROCK1,	ROCK2	and	cAMP-dependent	
protein	kinase),	HA-1000	hydrochloride	(a	metabolite	of	fasudil	hydrochloride;	a	selective	
ROCK1	and	ROCK2	inhibitor)	or	GSK-429286	(a	selective	ROCK1	and	ROCK2	inhibitor)	with	no	
loss	of	efficacy	[317].	
	
The	mechanism	of	Y-27632	has	not	been	addressed	in	these	studies;	however,	under	
conventional	culture	conditions,	cumulative	passage	may	reduce	the	number	of	
stem/progenitor	cells	by	inducing	anoikis	or	terminal	differentiation.	In	fact,	inhibition	of	
ROCK	signalling	might	be	an	effective	strategy	against	both	of	these	possibilities.	Firstly,	
ROCK	activation	is	implicated	in	apoptotic	pathways.	The	inhibitor	used	here,	Y-27632,	was	
identified	in	a	screen	of	molecules	to	inhibit	dissociation-induced	apoptosis	in	cultured	
human	embryonic	stem	cells	[318].	Although	ROCK	activation	occurs	as	a	late	event	in	the	
apoptotic	signalling	cascade	[319],	sudden	high	intensity	ROCK	activation	as	a	result	of	acute	
stress,	such	as	cell	dissociation,	may	accelerate	apoptosis	[320].	ROCK	inhibition	also	inhibits	
apoptosis	induced	by	the	loss	of	cadherin-dependent	cell	contacts	in	multiple	cell	types	[318,	
321,	322].	Secondly,	RhoA/ROCK	signals	mediate	terminal	differentiation	in	epithelial	cells	
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and	inhibition	of	ROCK	prevents	differentiation	[323].	In	differentiation	pathways,	upstream	
activation	of	ROCK	is	caused	by	Notch	1,	expression	of	which	is	low	in	ΔN-p63-expressing	
basal	epithelial	cells	[324]	and	high	in	suprabasal	keratinocytes	expressing	p53	and/or	TA-
p63	isoforms	[325].	Gene	expression	analyses	in	epidermal	keratinocytes	show	that	inclusion	
of	Y-27632	in	cultures	using	3T3-J2	feeder	cells	leads	to	downregulated	expression	of	
loricrin,	filaggrin	[317]	and	keratins	that	are	expressed	by	differentiated	keratinocytes	and	to	
upregulation	of	the	Notch	pathway	inhibitory	protein	CHAC1	[307].	Indeed,	calcium	
chelation	by	EDTA,	routinely	used	in	cell	culture,	leads	to	release	of	the	Notch	1	intracellular	
fragment	and	to	immediate	ROCK	activation	[326].	As	Notch	signalling	also	mediates	
differentiation	of	airway	basal	cells	[158],	this	might	provide	a	plausible	mechanism	for	the	
expansion	of	airway	basal	cells	in	3T3+Y.	Accordingly,	small	molecule	inhibition	of	ROCK	
might	act	both	to	prevent	dissociation-induced	anoikis	and	to	retain	the	proliferative	
fraction	of	undifferentiated	epithelial	stem/progenitor	cells	but	further	mechanistic	studies	
are	required	to	define	its	contribution	and	the	requirements	for	additional	activation	and/or	
repression	of	other	signalling	pathways.	
	
HGF	signalling	in	cultured	primary	human	airway	epithelial	cells	
	
The	data	presented	here	suggest	that	secreted	factors	mediate	the	effect	of	3T3-J2	co-
culture	but	that	they	are	required	in	constant	supply	for	their	effect.	These	data	support	the	
view	that	mechanisms	of	action	involving	direct	cell-cell	contact	[278]	or	extracellular	matrix	
deposition	[327]	can	be	ruled	out.	Searching	for	soluble	mediators	revealed	that	surprisingly	
few	growth	factor	receptor-associated	pathways	are	activated	in	human	airway	epithelial	
cells	co-cultured	with	3T3-J2	feeder	cells,	although	one	limitation	of	these	experiments	is	
that	conditioned	medium	from	mitotically	inactivated	fibroblasts	was	used	rather	than	from	
co-cultures	of	epithelial	cells	and	fibroblasts.	This	strategy	allowed	us	to	distinguish	potential	
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contributions	of	feeder	cells	but	could	not	identify	feeder	cell	factors	that	are	induced	by	
epithelial-derived	signals	[328].	Nevertheless,	hepatocyte	growth	factor	(HGF)-MET	
signalling	emerged	as	a	promising	candidate	mediating	feeder	cell-epithelial	cell	crosstalk	as	
it	was	secreted	by	feeder	cells	in	increasing	amounts	following	mitotic	inactivation	and	
activated	MET	on	human	epithelial	cells.	This	is	consistent	with	the	physiological	role	of	HGF-
MET	signalling,	where	mesenchyme-derived	HGF	signals	to	epithelial	MET	to	mediate	
diverse	responses	such	as	proliferation,	migration,	survival	and	differentiation	[283].	The	
identification	of	MET	activation	in	human	epithelial	cells	stimulated	with	3T3-J2-conditioned	
medium	was	particularly	interesting	as	murine	HGF	is	not	thought	to	bind	efficiently	to	the	
human	MET	receptor	[284].	Indeed,	autophosphorylation	of	the	MET	receptor	
multisubstrate-docking	site	was	reduced	in	response	to	murine	HGF	in	3T3-J2-conditioned	
medium	compared	with	recombinant	human	HGF.	Interestingly,	inhibition	of	MET	did	not	
decrease	proliferation	caused	by	conditioned	medium,	suggesting	that	HGF	signalling	is	
unlikely	to	be	responsible	for	this	aspect	of	the	improved	epithelial	cell	culture	conditions	
conferred	by	3T3+Y.	
	
Despite	this,	characterisation	of	signalling	downstream	of	MET	in	response	to	3T3-J2-
conditioned	medium	identified	the	transcription	factor	signal	transducer	and	activator	of	
transcription	6	(STAT6)	as	a	novel	target	of	MET	signalling,	a	finding	validated	using	
recombinant	human	HGF.	STAT6	is	a	target	of	interleukin-4	(IL-4)/IL-13	[329]	and	this	
cytokine	signalling	pathway	is	directly	involved	in	the	pathogenesis	of	airway	disease	[290,	
330].	In	separate	studies,	HGF	induced	cultured	proximal	airway	basal	cell	secretion	of	the	
neutrophil	chemoattractants	IL-8	and	granulocyte/macrophage	colony-stimulating	factor	
(GM-CSF),	consistent	with	recent	findings	that	these	cytokines	are	secreted	in	a	MET-
dependent	manner	in	alveolar	epithelial	cells	following	influenza	infection	[331].	The	
hypothesis	that	HGF	induction	of	IL-8	is	dependent	on	STAT6	was	tested	but	HGF	could	not	
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induce	expression	of	luciferase	from	a	STAT6	consensus	sequence	in	a	cancer	cell	line.	In	
addition,	phosphorylated	STAT6	remained	in	the	cytoplasm	of	human	airway	basal	cells	in	
response	to	HGF	stimulation,	in	contrast	to	following	activation	by	IL-13,	which	stimulates	
STAT6	nuclear	translocation	[61].	Further,	HGF	induced	IL-8	promoter	activation	in	luciferase	
assays	in	the	absence	of	the	upstream	STAT6-binding	sequence,	suggesting	that	other	
transcription	factors	such	as	nuclear	factor-κB	(NF-κB)	or	activator	protein	1	(AP-1),	rather	
than	STAT6,	mediate	the	HGF-induced	increase	in	IL-8	expression	and	secretion.	Previous	
data	show	that	cytoplasmic	phosphorylated	STAT6	cannot	bind	to	DNA	in	vitro	but	that	DNA-
binding	ability	could	be	conferred	by	detergent	treatment,	suggesting	the	existence	of	a	
cytoplasmic	inhibitor	of	phosphorylated	STAT6	[332].	Although	the	identity	of	this	inhibitor	
and	the	mechanism	of	inhibition	are	unknown,	one	possibility	is	that	a	bound	factor	both	
prevents	the	nuclear	import	of	STAT6	and	masks	the	DNA-binding	site.	Importin-α5	binds	
competitively	to	the	STAT1	DNA-binding	site	[333],	giving	biological	precedent	to	this	
hypothesis	but	experiments	comparing	proteins	bound	to	phosphorylated	STAT6	in	response	
to	HGF	and	IL-13	stimulation	using	co-immunoprecipitation	and	mass	spectrometry	are	
required	to	test	this	hypothesis.	Overall,	these	results	suggest	that	murine	HGF	cannot	be	
considered	to	be	completely	inactive	on	human	cells	and	that	it	may	still	have	an	unknown	
role	in	some	of	the	effects	of	3T3+Y	on	human	airway	epithelial	cells	but	that	other	secreted	
factors	most	likely	co-operate	with	ROCK	inhibition	to	improve	human	airway	basal	cell	
phenotype	in	3T3+Y.	Although	the	classic	proliferative	and	migratory	effects	of	HGF	are	
lacking	following	stimulation	with	murine	HGF,	some	intracellular	signalling	proceeds,	
including	the	phosphorylation	of	STAT6,	although	the	functional	role	of	these	signalling	
events	remains	to	be	explored.	
	
		
162	
 
Conclusion	
	
The	work	presented	here	identifies	problems	in	the	use	of	existing	cell	culture	protocols	for	
in	vitro	investigations	requiring	large	numbers	of	primary	human	airway	epithelial	cells	and	
for	potential	tissue-engineering	applications	that	require	patient	autologous	epithelial	cells	
because	of	the	limited	ability	to	expand	basal	cells	that	retain	key	stem/progenitor	cell	
functions.	I	have	characterised	an	alternative	cell	culture	protocol	involving	co-culture	of	
primary	epithelial	cells	with	3T3-J2	mouse	embryonic	fibroblast	feeder	cells	in	medium	
containing	a	Rho-associated	protein	kinase	(ROCK)	inhibitor,	Y-27632,	and	found	that	this	
system	is	better	at	retaining	basal	cell	function	in	in	vitro	assays.	As	similar	culture	protocols	
have	been	applied	clinically	in	the	treatment	of	limbal	stem	cell	deficiency	and	severe	burns	
injury,	I	am	hopeful	that	this	protocol	could	be	used	to	improve	the	prognosis	of	patients	in	
future	airway	transplantation	procedures	and	that	these	findings	might	be	a	platform	to	
discover	a	feeder-free	method	to	culture	human	airway	epithelial	cells	with	the	efficiency	
required	for	functional	transplantation.	Finally,	I	have	characterised	the	role	of	hepatocyte	
growth	factor	(HGF)	signalling	in	feeder	cell-epithelial	cell	crosstalk,	finding	that	murine	HGF	
activates	the	human	MET	receptor	and	downstream	signalling	processes	involving	
phosphorylation	of	GRB2-associated-binding	protein	2	(GAB2)	and	signal	transducer	and	
activator	of	transcription	6	(STAT6).	However,	the	functional	role	of	these	signalling	events	is	
unclear.									
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